Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
Lancet
    April 2024
  1. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    >> Share

  2. ADEPOJU P
    Moderna stalls on African vaccine manufacturing plans.
    Lancet. 2024;403:1617.
    >> Share

  3. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    >> Share

  4. DEVI S
    Swedish NGOs are reeling after government cuts.
    Lancet. 2024;403:1527.
    >> Share


  5. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    >> Share

  6. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    >> Share

  7. PETO L, Basnyat B, Horby P
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
    Lancet. 2024;403:1339-1340.
    >> Share

  8. BHUSAL S, Adhikari S
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1339.
    >> Share

  9. NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338-1339.
    >> Share

  10. HSU NC, Tokuda Y
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338.
    >> Share

  11. MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337.
    >> Share

  12. HASHIM Z, Nath A, Tripathy NK
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337-1338.
    >> Share

  13. SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
    Lancet. 2024;403:1336.
    >> Share

  14. GU X, Huang L, Zhang H, Cao B, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
    Lancet. 2024;403:1336-1337.
    >> Share


  15. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    >> Share

    March 2024
  16. KULKARNI PS, Potey AV, Bharati S, Kunhihitlu A, et al
    The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.
    Lancet. 2024 Mar 28:S0140-6736(24)00249-6. doi: 10.1016/S0140-6736(24)00249.
    >> Share

  17. SZANYI J, Howe S, Blakely T
    The importance of reporting accurate estimates of long COVID prevalence.
    Lancet. 2024;403:1136-1137.
    >> Share

  18. WENHAM C, Stout L
    A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
    Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
    >> Share

  19. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
    Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
    Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
    >> Share


  20. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    >> Share

  21. PARHIZ H, Atochina-Vasserman EN, Weissman D
    mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
    >> Share

    February 2024
  22. DHAIRYAWAN R
    Candour, care, and COVID-19.
    Lancet. 2024;403:718.
    >> Share

  23. VORA NM, Hassan L, Plowright RK, Horton R, et al
    The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
    Lancet. 2024;403:597-599.
    >> Share

  24. WALLER BY, Joseph VA, Keyes KM
    Racial inequities in homicide rates and homicide methods among Black and White women aged 25-44 years in the USA, 1999-2020: a cross-sectional time series study.
    Lancet. 2024 Feb 8:S0140-6736(23)02279-1. doi: 10.1016/S0140-6736(23)02279.
    >> Share

    January 2024
  25. MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
    The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
    Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
    >> Share

  26. WANG L, Wang Q, Gao GF
    Interpreting COVID-19 data from China: a call for caution - Authors' reply.
    Lancet. 2024;403:144-145.
    >> Share

  27. QU Z
    Interpreting COVID-19 data from China: a call for caution.
    Lancet. 2024;403:144.
    >> Share

  28. GULLIFORD MC, Steves CJ
    Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
    Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
    >> Share


  29. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
    >> Share

  30. SHAH SA, Robertson C, Sheikh A
    Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study.
    Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744.
    >> Share

    December 2023

  31. How modelling can better support public health policy making: the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases.
    Lancet. 2023 Dec 20:S0140-6736(23)02758-7. doi: 10.1016/S0140-6736(23)02758.
    >> Share

  32. GILES-VERNICK T, Cheah PY, Matta G, Lima NT, et al
    Louis Pasteur, COVID-19, and the social challenges of epidemics.
    Lancet. 2023;400:2166-2168.
    >> Share

  33. CHARLIER P
    Death and end of life in France after COVID-19.
    Lancet. 2023;402:2290.
    >> Share

  34. HORTON R
    Offline: Boris Johnson and COVID-19-more light than heat.
    Lancet. 2023;402:2277.
    >> Share

    November 2023
  35. POESPOPRODJO JR, Douglas NM, Ansong D, Kho S, et al
    Malaria.
    Lancet. 2023 Nov 1:S0140-6736(23)01249-7. doi: 10.1016/S0140-6736(23)01249.
    >> Share

  36. ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al
    Impact of long COVID-19 on work: a co-produced survey.
    Lancet. 2023;402 Suppl 1:S98.
    >> Share

  37. VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al
    The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities.
    Lancet. 2023;402 Suppl 1:S94.
    >> Share

  38. WRENN K, Blomquist PB, Inzoungou-Massanga C, Olufon O, et al
    Surge of lower respiratory tract group A streptococcal infections in England in winter 2022: epidemiology and clinical profile.
    Lancet. 2023;402 Suppl 1:S93.
    >> Share

  39. RAMASAWMY M, Khan N, Sunkersing D, Banerjee A, et al
    Understanding ethnic inequalities in the design and implementation of digital health interventions for cardiometabolic disease: a qualitative study.
    Lancet. 2023;402 Suppl 1:S78.
    >> Share


  40. Nowcasting waiting lists for elective procedures and surgery in England: a modelling study.
    Lancet. 2023;402 Suppl 1:S74.
    >> Share

  41. MURPHY MH, O'Kane SM, Carlin A, Lahart IM, et al
    A peer-led walking intervention for adolescent girls (the WISH study): a cluster-randomised controlled trial.
    Lancet. 2023;402 Suppl 1:S72.
    >> Share

  42. MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB
    Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study.
    Lancet. 2023;402 Suppl 1:S71.
    >> Share

  43. MARTIN A, Jamieson S
    Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
    Lancet. 2023;402 Suppl 1:S68.
    >> Share

  44. KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al
    Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
    Lancet. 2023;402 Suppl 1:S62.
    >> Share

  45. KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al
    Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
    Lancet. 2023;402 Suppl 1:S61.
    >> Share

  46. KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al
    Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2023;402 Suppl 1:S60.
    >> Share

  47. HINDOCHA A, Brennan L, Brewster L, Lunn J, et al
    The wider health and wellbeing needs of those accessing paediatric care in England: engaging with the hidden voices of children and young people.
    Lancet. 2023;402 Suppl 1:S50.
    >> Share

  48. HAZIR SG, Ryan C, Moore A, Lewis C, et al
    The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
    Lancet. 2023;402 Suppl 1:S47.
    >> Share

  49. DU Z, Wang L, Bai Y, Pei Y, et al
    Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study.
    Lancet. 2023;402 Suppl 1:S39.
    >> Share

  50. DOBBIN J, Soares CA, Burns F, Miall N, et al
    Medical consequences of "contingency accommodation" for people seeking asylum: thematic analysis of a survey from professionals working in contingency accommodation.
    Lancet. 2023;402 Suppl 1:S38.
    >> Share

  51. ARNOTT J, Troya MI, Joyce M, Khashan A, et al
    Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study.
    Lancet. 2023;402 Suppl 1:S23.
    >> Share

  52. ACHARYA A, Darzi A, Judah G
    An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial.
    Lancet. 2023;402 Suppl 1:S17.
    >> Share

    October 2023
  53. WANG Q, Bowen A, Ho J, Zhang RM, et al
    SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
    Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278.
    >> Share

  54. ABBASI K, Ali P, Barbour V, Benfield T, et al
    Time to treat the climate and nature crisis as one indivisible global health emergency.
    Lancet. 2023 Oct 25:S0140-6736(23)02289-4. doi: 10.1016/S0140-6736(23)02289.
    >> Share

  55. FRANK J, Mustard C, Smith P, Siddiqi A, et al
    Work as a social determinant of health in high-income countries: past, present, and future.
    Lancet. 2023;402:1357-1367.
    >> Share

  56. DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
    Scientific advisory councils in the COVID-19 response.
    Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
    >> Share

    September 2023
  57. HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply.
    Lancet. 2023;402:1132.
    >> Share

  58. MATUCHANSKY C
    Natural SARS-CoV-2 infection-induced immune protection against re-infection.
    Lancet. 2023;402:1131.
    >> Share

  59. ZHOU YB, Xu ZG
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
    Lancet. 2023;402:1131-1132.
    >> Share

  60. QU Z
    Cautionary notes on the COVID-19 re-infection study.
    Lancet. 2023;402:1130-1131.
    >> Share

  61. FLACCO ME, Martellucci CA, Manzoli L
    Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
    Lancet. 2023;402:1129.
    >> Share

  62. YANG C, Lapp L, Tebbutt SJ
    Overcoming COVID-19 vaccine hesitancy hurdles.
    Lancet. 2023;402:1129-1130.
    >> Share

  63. TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al
    Striving to afford free health care in Greece during COVID-19.
    Lancet. 2023;402:1128-1129.
    >> Share

  64. PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al
    Community COVID-19 response in WHO's European region.
    Lancet. 2023;402:1127.
    >> Share

  65. UMAR TP
    Arcturus (XBB.1.16) COVID-19 subvariant emergence in Indonesia.
    Lancet. 2023;402:1127-1128.
    >> Share

  66. JASSAT W, Reyes LF, Munblit D, Caoili J, et al
    Long COVID in low-income and middle-income countries: the hidden public health crisis.
    Lancet. 2023;402:1115-1117.
    >> Share

  67. MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
    Lancet. 2023;402:1041-1042.
    >> Share

  68. PARENTE RCM, Queiroga M
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
    Lancet. 2023;402:1040-1041.
    >> Share

  69. ZHANG H
    COVID-19 and Chinese nurses' mental health.
    Lancet. 2023;402:1039-1040.
    >> Share

  70. HEYMANS S, Lakdawala NK, Tschope C, Klingel K, et al
    Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.
    Lancet. 2023;402:998-1011.
    >> Share

  71. DZAU V, Swaminathan S, Baker C, Bright RA, et al
    The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation.
    Lancet. 2023 Sep 5:S0140-6736(23)01775-0. doi: 10.1016/S0140-6736(23)01775.
    >> Share

  72. PERCIVAL V, Thoms OT, Oppenheim B, Rowlands D, et al
    The Lancet Commission on peaceful societies through health equity and gender equality.
    Lancet. 2023 Sep 4:S0140-6736(23)01348-X. doi: 10.1016/S0140-6736(23)01348.
    >> Share

    August 2023
  73. DAI L, Duan H, Liu X, Zhou H, et al
    Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
    Lancet. 2023;402:687-689.
    >> Share

  74. KUNG S, Hills T, Kearns N, Beasley R, et al
    New Zealand's COVID-19 elimination strategy and mortality patterns.
    Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
    >> Share

  75. IFTEKHAR N, Sivan M
    Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
    Lancet. 2023;402:e9.
    >> Share

  76. KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
    Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
    Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
    >> Share

    July 2023
  77. HSU NC, Hsu CH
    COVID-19 and commerce complicate minimum unit pricing effects on health.
    Lancet. 2023;402:368.
    >> Share

  78. WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
    COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
    Lancet. 2023;402:368-369.
    >> Share


  79. Pandemics move faster than funders.
    Lancet. 2023;402:367.
    >> Share

  80. ZHOU J, Zhang Y, Mo K, Newbert H, et al
    mRNA vaccines do not stop with COVID-19.
    Lancet. 2023 Jul 27:S0140-6736(23)01514-3. doi: 10.1016/S0140-6736(23)01514.
    >> Share

  81. O'BRIEN KL, Lemango E
    The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
    Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
    >> Share

  82. RIFE EC, Cron RQ
    Janus kinase inhibition in juvenile idiopathic arthritis.
    Lancet. 2023 Jul 6:S0140-6736(23)01134-0. doi: 10.1016/S0140-6736(23)01134.
    >> Share

    June 2023

  83. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    >> Share

  84. WIJAYA R, Johnson M, Campbell N, Stuart B, et al
    Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
    Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180.
    >> Share

  85. PELOSI A
    Disrespectful language about patients with long COVID.
    Lancet. 2023;401:2108.
    >> Share

  86. PRIYA GIRI S, Dubey A
    Loneliness in the time of COVID-19: an alarming rise.
    Lancet. 2023;401:2107-2108.
    >> Share

  87. BAILEY C, Sanderson T, Townsley H, Goldman J, et al
    Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
    Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917.
    >> Share

  88. LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al
    Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
    Lancet. 2023;401:2021-2023.
    >> Share

  89. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
    >> Share

  90. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    >> Share

  91. THE LANCET EDITORS
    Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 9:S0140-6736(23)01175-3. doi: 10.1016/S0140-6736(23)01175.
    >> Share

  92. WOLF J, Johnston RB, Ambelu A, Arnold BF, et al
    Burden of disease attributable to unsafe drinking water, sanitation, and hygiene in domestic settings: a global analysis for selected adverse health outcomes.
    Lancet. 2023 Jun 5:S0140-6736(23)00458-0. doi: 10.1016/S0140-6736(23)00458.
    >> Share

    May 2023
  93. JAFFE S
    US health experts divided on social media age restrictions.
    Lancet. 2023;401:1757.
    >> Share


  94. Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
    Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
    >> Share

  95. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
    >> Share

  96. ZAROCOSTAS J
    With the COVID-19 PHEIC over, what next?
    Lancet. 2023;401:1642-1643.
    >> Share

  97. MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al
    Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
    Lancet. 2023;401:1649.
    >> Share

  98. JAFFE S
    US Surgeon General: loneliness is a public health crisis.
    Lancet. 2023;401:1560.
    >> Share

  99. EMANUEL EJ, Persad G
    The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19.
    Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812.
    >> Share

    April 2023
  100. AGRAWAL U, Robertson C, Sheikh A
    Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
    Lancet. 2023;401:1424.
    >> Share

  101. BRANCH-ELLIMAN W, Monach PA
    Moving towards a precision approach for prevention of severe COVID-19.
    Lancet. 2023;401:1423-1424.
    >> Share

  102. SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al
    The importance of accountability in tackling future pandemics.
    Lancet. 2023;401:1423.
    >> Share

  103. GALVAO J
    COVID-19: forgetting a pandemic that is not over.
    Lancet. 2023;401:1422-1423.
    >> Share

  104. THE LANCET
    Moving past the COVID-19 emergency in the USA.
    Lancet. 2023;401:1399.
    >> Share

  105. ROSS I, Bick S, Ayieko P, Dreibelbis R, et al
    Effectiveness of handwashing with soap for preventing acute respiratory infections in low-income and middle-income countries: a systematic review and meta-analysis.
    Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021.
    >> Share

  106. CUENI T
    Lessons learned from COVID-19 to stop future pandemics.
    Lancet. 2023;401:1340.
    >> Share

  107. HORTON R
    Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
    Lancet. 2023;401:1324.
    >> Share

  108. LURIE N, Sharfstein JM
    State-to-state differences in US COVID-19 outcomes: searching for explanations.
    Lancet. 2023;401:1314-1315.
    >> Share

  109. PETROV AN, Dorough DS, Tiwari S, Welford M, et al
    Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
    Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684.
    >> Share

  110. HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al
    Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?
    Lancet. 2023;401:e20.
    >> Share

  111. GOH AXC, Chae SR, Chiew CJ, Tang N, et al
    Characteristics of the omicron XBB subvariant wave in Singapore.
    Lancet. 2023;401:1261-1262.
    >> Share

  112. KING B, Zhang X, Harcha WG, Szepietowski JC, et al
    Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
    Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222.
    >> Share


  113. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510.
    >> Share

  114. PERNER A, Venkatesh B
    Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
    Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587.
    >> Share

    March 2023
  115. THE EDITORS OF THE LANCET
    Retraction-Chinese medical personnel after the COVID-19 pandemic.
    Lancet. 2023;401:1141.
    >> Share

  116. SUN L, Jia H, Yang T
    Chinese medical personnel after the COVID-19 pandemic.
    Lancet. 2023;401:1000.
    >> Share

  117. FRIEL S, Collin J, Daube M, Depoux A, et al
    Commercial determinants of health: future directions.
    Lancet. 2023 Mar 22:S0140-6736(23)00011-9. doi: 10.1016/S0140-6736(23)00011.
    >> Share

  118. GILMORE AB, Fabbri A, Baum F, Bertscher A, et al
    Defining and conceptualising the commercial determinants of health.
    Lancet. 2023 Mar 22:S0140-6736(23)00013-2. doi: 10.1016/S0140-6736(23)00013.
    >> Share

  119. BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al
    Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461.
    >> Share


  120. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
    Lancet. 2023;401:833-842.
    >> Share

  121. COHEN C, Pulliam J
    COVID-19 infection, reinfection, and the transition to endemicity.
    Lancet. 2023;401:798-800.
    >> Share

  122. QU Z
    International cooperation to end the COVID-19 pandemic.
    Lancet. 2023;401:820.
    >> Share

  123. THE LANCET
    Long COVID: 3 years in.
    Lancet. 2023;401:795.
    >> Share

  124. CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al
    Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.
    Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136.
    >> Share

    February 2023
  125. HUANG S, Gao Z, Wang S
    China's COVID-19 reopening measures-warriors and weapons.
    Lancet. 2023;401:643-644.
    >> Share

  126. HAY SI, Murray CJL
    Conflicting COVID-19 excess mortality estimates - Authors' reply.
    Lancet. 2023;401:433-434.
    >> Share

  127. BAGER P, Nielsen J, Bhatt S, Nielsen LB, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432-433.
    >> Share

  128. DONZELLI A
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432.
    >> Share

  129. MOETI M, Makubalo L, Gueye AS, Balde T, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    >> Share

  130. O'NEILL D
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    >> Share

  131. SCHOLEY J, Karlinsky A, Kobak D, Tallack C, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431-432.
    >> Share

  132. PAN Y, Wang L, Feng Z, Xu H, et al
    Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
    Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129.
    >> Share

  133. PREISER W, Maponga T
    So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward.
    Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268.
    >> Share

  134. TAN H, Liu J, Zeng F
    China needs a scientific long COVID recovery-support platform.
    Lancet. 2023;401:344-345.
    >> Share

    January 2023
  135. MOHEBBI N, Ritter A, Wiegand A, Graf N, et al
    Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
    Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606.
    >> Share

  136. ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al
    Global and regional governance of One Health and implications for global health security.
    Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597.
    >> Share

  137. TRAORE T, Shanks S, Haider N, Ahmed K, et al
    How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
    Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589.
    >> Share

  138. MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al
    A global analysis of One Health Networks and the proliferation of One Health collaborations.
    Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596.
    >> Share

  139. ELLINGTON S, Jatlaoui TC
    COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy.
    Lancet. 2023 Jan 17:S0140-6736(22)02613-7. doi: 10.1016/S0140-6736(22)02613.
    >> Share

  140. VILLAR J, Soto Conti CP, Gunier RB, Ariff S, et al
    Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
    Lancet. 2023 Jan 17:S0140-6736(22)02467-9. doi: 10.1016/S0140-6736(22)02467.
    >> Share

  141. THE LANCET
    The COVID-19 pandemic in 2023: far from over.
    Lancet. 2023;401:79.
    >> Share

  142. BAKER MG, Durrheim D, Hsu LY, Wilson N, et al
    COVID-19 and other pandemics require a coherent response strategy.
    Lancet. 2023 Jan 13:S0140-6736(22)02489-8. doi: 10.1016/S0140-6736(22)02489.
    >> Share

    December 2022
  143. TIBBLE H, Mueller T, Proud E, Hall E, et al
    Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland.
    Lancet. 2022 Dec 22:S0140-6736(22)02398-4. doi: 10.1016/S0140-6736(22)02398.
    >> Share

  144. KIDD MR, Kelly PM
    PANORAMIC: important insights into molnupiravir use in COVID-19.
    Lancet. 2022 Dec 22:S0140-6736(22)02593-4. doi: 10.1016/S0140-6736(22)02593.
    >> Share

  145. BUTLER CC, Hobbs FDR, Gbinigie OA, Rahman NM, et al
    Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
    Lancet. 2022 Dec 22:S0140-6736(22)02597-1. doi: 10.1016/S0140-6736(22)02597.
    >> Share

  146. SELVARAJAH S, Corona Maioli S, Deivanayagam TA, de Morais Sato P, et al
    Racism, xenophobia, and discrimination: mapping pathways to health outcomes.
    Lancet. 2022;400:2109-2124.
    >> Share

  147. DEVAKUMAR D, Selvarajah S, Abubakar I, Kim SS, et al
    Racism, xenophobia, discrimination, and the determination of health.
    Lancet. 2022;400:2097-2108.
    >> Share

  148. ELSON W, Zambon M, de Lusignan S
    Integrated respiratory surveillance after the COVID-19 pandemic.
    Lancet. 2022;400:1924-1925.
    >> Share

    November 2022
  149. THE LANCET EDITORS
    Expression of concern: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2022 Nov 24:S0140-6736(22)02370-4. doi: 10.1016/S0140-6736(22)02370.
    >> Share

  150. HORTON R
    Offline: COVID-19-the lessons that science forgot.
    Lancet. 2022;400:1753.
    >> Share


  151. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 Nov 18:S0140-6736(22)02185-7. doi: 10.1016/S0140-6736(22)02185.
    >> Share

  152. GOSTIN LO, Friedman EA, Hossain S, Mukherjee J, et al
    Human rights and the COVID-19 pandemic: a retrospective and prospective analysis.
    Lancet. 2022 Nov 17:S0140-6736(22)01278-8. doi: 10.1016/S0140-6736(22)01278.
    >> Share

  153. OWEN A, Diaz JV, Guyatt G, Lamontagne F, et al
    WHO Living Guidelines on antivirals for COVID-19 are evidence-based.
    Lancet. 2022 Nov 10. pii: S0140-6736(22)02306.
    >> Share

  154. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    >> Share

  155. DOWRICK A, Rai T, Hinton L, Eacott B, et al
    Health inequalities, ethnic minorities and COVID19: interactive theatre workshop drawing on a qualitative interview study.
    Lancet. 2022;400 Suppl 1:S9.
    >> Share

  156. ZURIAGA A, Flannigan L, Wilson J, Weiss S, et al
    A partnership approach to supporting the health and wellbeing of the Charedi (Orthodox Jewish) community in London.
    Lancet. 2022;400 Suppl 1:S85.
    >> Share

  157. PANTELIC M, Ziauddeen N, Boyes M, O'Hara ME, et al
    The prevalence of stigma in a UK community survey of people with lived experience of long COVID.
    Lancet. 2022;400 Suppl 1:S84.
    >> Share

  158. TWEED S
    Experience of homelessness during the COVID-19 pandemic in Tower Hamlets, London: a health needs assessment.
    Lancet. 2022;400 Suppl 1:S82.
    >> Share

  159. TURNER G, de'Donato F, Kovats S, Hoeben A, et al
    Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis.
    Lancet. 2022;400 Suppl 1:S81.
    >> Share

  160. TORRESIN S, Ratcliffe E, Aletta F, Albatici R, et al
    The effect of indoor soundscape on sexual wellbeing during the COVID-19 lockdown in London: a thematic analysis of remote workers' experiences.
    Lancet. 2022;400 Suppl 1:S80.
    >> Share

  161. SCOTT S, McGowan VJ, Wildman JM, Bidmead E, et al
    COVID-19 and the role of Voluntary, Community, and Social Enterprises in northern England in responding to the needs of marginalised communities: a qualitative focus group study.
    Lancet. 2022;400 Suppl 1:S78.
    >> Share

  162. SERKA S, Mainwaring J
    Perspectives of education and mental health professionals on adolescent school-based mental health promotion: a qualitative exploration.
    Lancet. 2022;400 Suppl 1:S76.
    >> Share

  163. ROSENTHAL DM, Heys M, Schoenthaler A, Hayward A, et al
    How did living in temporary accommodation during the COVID-19 pandemic affect children younger than 5 years' access to health care and health outcomes? A qualitative study of key professionals in a socially and ethnically diverse and deprived area of
    Lancet. 2022;400 Suppl 1:S75.
    >> Share

  164. QI C, Osborne T, Bailey R, Hollinghurst J, et al
    Effect of the COVID-19 pandemic on incidence of long-term conditions in Welsh residents: a population linkage study.
    Lancet. 2022;400 Suppl 1:S69.
    >> Share

  165. NIRANJAN V, Fitzpatrick P, Morrogh R, O'Hagan K, et al
    Evaluation of community outreach feasibility programmes on improving cancer-related, preventive, health behaviour.
    Lancet. 2022;400 Suppl 1:S67.
    >> Share

  166. MCQUIRE C, Zuccolo L, Frennesson F, Butcher S, et al
    Prenatal alcohol prevention in the UK: mapping the landscape through systematic collaborative review.
    Lancet. 2022;400 Suppl 1:S64.
    >> Share

  167. MCKINLAY AR, Collins L, Fancourt D, Burton A, et al
    How did female survivors of abuse use the arts to support their mental health and wellbeing during the COVID-19 pandemic? A qualitative exploration of their views.
    Lancet. 2022;400 Suppl 1:S63.
    >> Share

  168. PARNHAM JC, Vamos EP, McKevitt S, Laverty AA, et al
    The UK's Free School Meals policy during the pandemic: a thematic content analysis of policy documents and debates.
    Lancet. 2022;400 Suppl 1:S62.
    >> Share

  169. TINNER L
    Exploring young people's perceptions of health and inequality through art: a co-produced qualitative study.
    Lancet. 2022;400 Suppl 1:S6.
    >> Share

  170. MAKANJUOLA A, Lynch M, Hartfiel N, Cuthbert A, et al
    Social return on investment of face-to-face versus online lifestyle coaching to improve mental wellbeing.
    Lancet. 2022;400 Suppl 1:S59.
    >> Share

  171. KEEBLE M, Adams J, Burgoine T
    Changes in online food access during the COVID-19 pandemic and associations with deprivation: a longitudinal analysis.
    Lancet. 2022;400 Suppl 1:S54.
    >> Share

  172. BURNS R, Campos-Matos I, Harron K, Aldridge RW, et al
    COVID-19 vaccination uptake for half a million non-EU migrants and refugees in England: a linked retrospective population-based cohort study.
    Lancet. 2022;400 Suppl 1:S5.
    >> Share

  173. GRAY BJ, Kyle RG, Challenger A, Davies AR, et al
    Mental health of the nursing and midwifery workforce in Wales during the COVID-19 pandemic: a cross-sectional analysis.
    Lancet. 2022;400 Suppl 1:S43.
    >> Share

  174. HUF SW, Woldmann L, Crespo RF, Grailey K, et al
    Implementing behavioural science informed letter interventions to increase COVID-19 vaccination uptake in uncontactable London residents: a difference-in-difference study in London, UK.
    Lancet. 2022;400 Suppl 1:S41.
    >> Share

  175. GEISMAR C, Nguyen V, Fragaszy E, Shrotri M, et al
    Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch).
    Lancet. 2022;400 Suppl 1:S40.
    >> Share

  176. DAWES J, May T, Fancourt D, Burton A, et al
    The impact of the COVID-19 pandemic on people experiencing homelessness: a qualitative interview study in the UK.
    Lancet. 2022;400 Suppl 1:S35.
    >> Share

  177. CURTIN EL, Widnall E, Dodd S, Limmer M, et al
    The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation.
    Lancet. 2022;400 Suppl 1:S34.
    >> Share

  178. BRIGHT D, Song J, Hillier S, Huws DW, et al
    Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study.
    Lancet. 2022;400 Suppl 1:S25.
    >> Share

  179. BEYNON C
    Exploring the association between obesity and problems with peer relationships in children: a nationally representative cross-sectional study.
    Lancet. 2022;400 Suppl 1:S21.
    >> Share

  180. BERNARD A, Salhi L, de Ossorno Garcia S, John A, et al
    Engagement of individuals aged 14-25 years with a digital mental health service during the COVID-19 pandemic in the UK: a cohort study of service usage data.
    Lancet. 2022;400 Suppl 1:S20.
    >> Share

  181. ANDREAE G, Scott S, Nguyen G, Bell Z, et al
    Food insecurity among pregnant women living in high-income countries: a systematic review.
    Lancet. 2022;400 Suppl 1:S17.
    >> Share

  182. GRIFFITHS ML, Gray BJ, Kyle RG, Davies AR, et al
    Shifting priorities and employment choices among workers in Wales during the COVID-19 pandemic: a longitudinal analysis.
    Lancet. 2022;400 Suppl 1:S1.
    >> Share

    October 2022

  183. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.
    Lancet. 2022 Oct 31. pii: S0140-6736(22)01846.
    >> Share

  184. FRENK J, Chen LC, Chandran L, Groff EOH, et al
    Challenges and opportunities for educating health professionals after the COVID-19 pandemic.
    Lancet. 2022;400:1539-1556.
    >> Share

  185. DAS M, Keke K
    Pandemic solidarity across national borders saved lives.
    Lancet. 2022;400:1510-1511.
    >> Share

  186. AGUS DB, Nguyen A, Sall AA, Bell J, et al
    COVID-19 and other adult vaccines can drive global disease prevention.
    Lancet. 2022 Oct 27. pii: S0140-6736(22)02084.
    >> Share

  187. OPEL DJ, Brewer NT, Buttenheim AM, Callaghan T, et al
    The legacy of the COVID-19 pandemic for childhood vaccination in the USA.
    Lancet. 2022 Oct 26. pii: S0140-6736(22)01693.
    >> Share

  188. LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al
    After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
    Lancet. 2022 Oct 21. pii: S0140-6736(22)01840.
    >> Share

  189. AGRAWAL U, Bedston S, McCowan C, Oke J, et al
    Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2022;400:1305-1320.
    >> Share

  190. MSELLATI P, Sow K, Desclaux A, Cottrell G, et al
    Reconsidering the COVID-19 vaccine strategy in West and Central Africa.
    Lancet. 2022;400:1304.
    >> Share

  191. IRVING SA, Sundaram ME
    Prioritisation of COVID-19 boosters in the omicron era.
    Lancet. 2022;400:1282-1283.
    >> Share

  192. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
    Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
    Lancet. 2022;400:1213-1222.
    >> Share

  193. BURDET C, Ader F
    Real-world effectiveness of oral antivirals for COVID-19.
    Lancet. 2022;400:1175-1176.
    >> Share

  194. FRENK J, Godal T, Gomez-Dantes O, Store JG, et al
    A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic.
    Lancet. 2022 Oct 7. pii: S0140-6736(22)01943.
    >> Share

  195. WU MY, Carr EJ, Harvey R, Mears HV, et al
    WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
    Lancet. 2022 Oct 6. pii: S0140-6736(22)01938.
    >> Share

    September 2022
  196. HAMEED SS, Hall E, Grange Z, Sullivan C, et al
    Characterising adults in Scotland who are not vaccinated against COVID-19.
    Lancet. 2022;400:993-995.
    >> Share

  197. THE LANCET
    COVID-19: the case for prosociality.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01761.
    >> Share

  198. SACHS JD, Karim SSA, Aknin L, Allen J, et al
    The Lancet Commission on lessons for the future from the COVID-19 pandemic.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01585.
    >> Share

  199. YEK C, Warner S, Mancera A, Kadri SS, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
    Lancet. 2022;400:809.
    >> Share

  200. NYBERG T, Ferguson NM, Blake J, Hinsley W, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
    Lancet. 2022;400:809-810.
    >> Share

  201. ZHANG Y, Wang Y, Ning G, He P, et al
    Protecting older people: a high priority during the COVID-19 pandemic.
    Lancet. 2022;400:729-730.
    >> Share

  202. THORNTON J
    New centre for pandemic therapeutics.
    Lancet. 2022;400:722.
    >> Share

  203. GORMAN EA, O'Kane CM, McAuley DF
    Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management.
    Lancet. 2022 Sep 2. pii: S0140-6736(22)01439.
    >> Share

    August 2022
  204. UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
    Influenza.
    Lancet. 2022;400:693-706.
    >> Share

  205. BOLLYKY TJ, Angelino O, Wigley S, Dieleman JL, et al
    Trust made the difference for democracies in COVID-19.
    Lancet. 2022;400:657.
    >> Share

  206. MOETI M, Gao GF, Herrman H
    Global pandemic perspectives: public health, mental health, and lessons for the future.
    Lancet. 2022;400:e3-e7.
    >> Share


  207. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022;400:563-591.
    >> Share

  208. HILL M, Bandyopadhyay AS, Pollard AJ
    Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use.
    Lancet. 2022 Aug 18. pii: S0140-6736(22)01582.
    >> Share

  209. BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
    Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
    Lancet. 2022;400:452-461.
    >> Share

  210. SORENSEN RJD
    COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
    Lancet. 2022;400:429-430.
    >> Share

  211. VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
    COVID-19 and microbiome diversity in sub-Saharan Africa.
    Lancet. 2022;400:429.
    >> Share

  212. BRIGHTLING CE, Evans RA
    Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
    Lancet. 2022;400:411-413.
    >> Share

    July 2022

  213. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
    Lancet. 2022;400:359-368.
    >> Share

  214. THORNTON J
    Violence against health workers rises during COVID-19.
    Lancet. 2022;400:348.
    >> Share

  215. MEHTA P, Titanji BK
    Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
    Lancet. 2022;400:338-339.
    >> Share

  216. LAWTON T, Alwan NA
    The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
    Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
    >> Share


  217. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    >> Share

  218. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
    Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
    Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
    >> Share

  219. DURRHEIM DN
    Perilous two-tier COVID-19 global vaccine roll-out.
    Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
    >> Share

  220. WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
    Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
    Lancet. 2022;400:93-96.
    >> Share

  221. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
    Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
    >> Share

  222. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    >> Share

  223. NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
    Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
    Lancet. 2022;400:24.
    >> Share

  224. PFAFF F, Hoffmann D, Beer M
    Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
    Lancet. 2022;400:22-23.
    >> Share

    June 2022
  225. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
    >> Share

  226. LADHANI SN
    COVID-19 vaccination for children aged 5-11 years.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
    >> Share

  227. BURKI T
    COVID-19 in North Korea.
    Lancet. 2022;399:2339.
    >> Share

  228. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
    Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
    Lancet. 2022;399:2263-2264.
    >> Share

  229. OFRI D
    Memorialising COVID-19.
    Lancet. 2022;399:2260-2261.
    >> Share

  230. LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
    Lancet. 2022;399:2212-2225.
    >> Share

  231. WONG HL, Hu M, Zhou CK, Lloyd PC, et al
    Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Lancet. 2022;399:2191-2199.
    >> Share

  232. PATEL M, Patel M
    Increasing children's global access to COVID-19 vaccines.
    Lancet. 2022;399:2171-2173.
    >> Share

  233. HUSBY A, Kober L
    COVID-19 mRNA vaccination and myocarditis or pericarditis.
    Lancet. 2022;399:2168-2169.
    >> Share

    May 2022
  234. CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
    Transforming or tinkering: the world remains unprepared for the next pandemic threat.
    Lancet. 2022;399:1995-1999.
    >> Share

  235. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    >> Share

  236. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
    Where is the next SARS-CoV-2 variant of concern?
    Lancet. 2022;399:1938-1939.
    >> Share

  237. KICKBUSCH I, Liu A
    Global health diplomacy-reconstructing power and governance.
    Lancet. 2022 May 17. pii: S0140-6736(22)00583.
    >> Share

  238. YUAN S
    Zero COVID in China: what next?
    Lancet. 2022;399:1856-1857.
    >> Share

  239. SHERLOCK PL
    COVID-19 and inter-generational solidarity.
    Lancet. 2022;399:1775.
    >> Share

  240. THE LANCET
    COVID-19: the next phase and beyond.
    Lancet. 2022;399:1753.
    >> Share

  241. BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
    Optimising child and adolescent health and development in the post-pandemic world.
    Lancet. 2022;399:1759-1761.
    >> Share

  242. JHA P, Brown PE, Ansumana R
    Counting the global COVID-19 dead.
    Lancet. 2022 May 6. pii: S0140-6736(22)00845.
    >> Share

  243. ZHANG X, Zhang W, Chen S
    Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.
    Lancet. 2022 May 6. pii: S0140-6736(22)00838.
    >> Share

  244. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
    Chronic obstructive pulmonary disease.
    Lancet. 2022 May 6. pii: S0140-6736(22)00470.
    >> Share

  245. DZAU VJ, Balatbat CA, Offodile AC 2nd
    Closing the global vaccine equity gap: equitably distributed manufacturing.
    Lancet. 2022 May 6. pii: S0140-6736(22)00793.
    >> Share


  246. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    Lancet. 2022 May 2. pii: S0140-6736(22)00519.
    >> Share

    April 2022
  247. ADEPOJU P
    Africa CDC warns COVID-19 vaccine production could cease.
    Lancet. 2022;399:1683.
    >> Share

  248. VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al
    Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs.
    Lancet. 2022;399:1741-1752.
    >> Share

  249. ARCHARD D, Buyx A, Delfraissy JF
    Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
    Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.
    >> Share

  250. GRAMMATOPOULOS DK, Young L, Anderson NR
    Transforming the UK's diagnostics agenda after COVID-19.
    Lancet. 2022;399:1606.
    >> Share

  251. JEFFORD M, Howell D, Li Q, Lisy K, et al
    Improved models of care for cancer survivors.
    Lancet. 2022;399:1551-1560.
    >> Share

  252. FISHER D, Suri S, Carson G
    What comes next in the COVID-19 pandemic?
    Lancet. 2022 Apr 11. pii: S0140-6736(22)00580.
    >> Share

  253. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    >> Share

  254. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    >> Share

  255. DWEK RA, Bell JI, Feldmann M, Zitzmann N, et al
    Host-targeting oral antiviral drugs to prevent pandemics.
    Lancet. 2022;399:1381-1382.
    >> Share


  256. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
    >> Share

  257. SHIODA K, Lopman B
    How to interpret the total number of SARS-CoV-2 infections.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
    >> Share

  258. MENNI C, Valdes AM, Polidori L, Antonelli M, et al
    Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00327.
    >> Share

  259. HAN X, Li J, Chen Y, Li Y, et al
    SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00577.
    >> Share

  260. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
    Acute coronary syndromes.
    Lancet. 2022;399:1347-1358.
    >> Share

  261. KHOBRAGADE A, Bhate S, Ramaiah V, Deshpande S, et al
    Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
    Lancet. 2022;399:1313-1321.
    >> Share

  262. ZAROCOSTAS J
    Mixed response to COVID-19 intellectual property waiver.
    Lancet. 2022;399:1292-1293.
    >> Share

  263. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    >> Share

  264. POST LA, Lorenzo-Redondo R
    Omicron: fewer adverse outcomes come with new dangers.
    Lancet. 2022;399:1280-1281.
    >> Share

    March 2022
  265. LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
    Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
    Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
    >> Share


  266. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
    Lancet. 2022;399:1266-1278.
    >> Share

  267. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    >> Share

  268. NIXON DF, Schwartz RE, Ndhlovu LC
    Booster vaccines for COVID-19 vaccine breakthrough cases?
    Lancet. 2022;399:1224.
    >> Share

  269. SWETS MC, Russell CD, Harrison EM, Docherty AB, et al
    SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
    Lancet. 2022 Mar 25. pii: S0140-6736(22)00383.
    >> Share

  270. KOLA L, Kumar M, Kohrt BA, Fatodun T, et al
    Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.
    Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
    >> Share

  271. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    >> Share

  272. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    >> Share

  273. PREISER W, Fish T
    Sisonke: reaching several goals together.
    Lancet. 2022;399:1095-1097.
    >> Share

  274. NYBERG T, Ferguson NM, Nash SG, Webster HH, et al
    Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Lancet. 2022 Mar 16. pii: S0140-6736(22)00462.
    >> Share

  275. REARTE A, Castelli JM, Rearte R, Fuentes N, et al
    Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00011.
    >> Share

  276. MILLS EJ, Reis G
    Evaluating COVID-19 vaccines in the real world.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00194.
    >> Share

  277. YEN HL, Sit THC, Brackman CJ, Chuk SSY, et al
    Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
    Lancet. 2022;399:1070-1078.
    >> Share

  278. HAAGMANS BL, Koopmans MPG
    Spreading of SARS-CoV-2 from hamsters to humans.
    Lancet. 2022;399:1027-1028.
    >> Share

  279. KHAN W, Abubakar A, Brennan RJ, Al Hosani F, et al
    Preparing for future pandemics in the Eastern Mediterranean region.
    Lancet. 2022;399:1032-1033.
    >> Share

  280. ABUBAKAR I, Dalglish SL, Angell B, Sanuade O, et al
    The Lancet Nigeria Commission: investing in health and the future of the nation.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02488.
    >> Share

  281. ANGELL B, Sanuade O, Adetifa IMO, Okeke IN, et al
    Population health outcomes in Nigeria compared with other west African countries, 1998-2019: a systematic analysis for the Global Burden of Disease Study.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02722.
    >> Share


  282. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    Lancet. 2022 Mar 10. pii: S0140-6736(21)02796.
    >> Share

  283. MANCA T, Baylis F, Munoz FM, Top KA, et al
    Prioritise research on vaccines for pregnant and breastfeeding women.
    Lancet. 2022;399:890-893.
    >> Share

  284. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    >> Share

  285. CORREIA LCL, Sette C, Santos M, Magliano CAS, et al
    Brazil's COVID-19 guidelines: political hijack of public health.
    Lancet. 2022 Mar 3. pii: S0140-6736(22)00338.
    >> Share

  286. KUCHARSKI AJ, Jit M, Logan JG, Cotten M, et al
    Travel measures in the SARS-CoV-2 variant era need clear objectives.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00366.
    >> Share

  287. FLOR LS, Friedman J, Spencer CN, Cagney J, et al
    Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
    >> Share

  288. MORGAN R, Pimenta DN, Rashid S
    Gender equality and COVID-19: act now before it is too late.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
    >> Share

    February 2022
  289. USHER AD
    The global COVID-19 treatment divide.
    Lancet. 2022;399:779-782.
    >> Share

  290. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    >> Share

  291. THE LANCET
    Our commitment to help accelerate progress against cancer.
    Lancet. 2022;399:769.
    >> Share


  292. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    Lancet. 2022 Feb 24. pii: S0140-6736(21)02867.
    >> Share

  293. GU X, Cao B
    Understanding of COVID-19 from infection-fatality ratio.
    Lancet. 2022 Feb 24. pii: S0140-6736(22)00281.
    >> Share

  294. BAJAJ SS, Maki L, Stanford FC
    Vaccine apartheid: global cooperation and equity.
    Lancet. 2022 Feb 23. pii: S0140-6736(22)00328.
    >> Share

  295. PIECHOTTA V, Harder T
    Waning of COVID-19 vaccine effectiveness: individual and public health risk.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00282.
    >> Share

  296. FEIKIN DR, Higdon MM, Abu-Raddad LJ, Andrews N, et al
    Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00152.
    >> Share

  297. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    >> Share

  298. KALAFAT E, Magee LA, von Dadelszen P, Heath P, et al
    COVID-19 booster doses in pregnancy and global vaccine equity.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00166.
    >> Share

  299. SARDINHA L, Maheu-Giroux M, Stockl H, Meyer SR, et al
    Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018.
    Lancet. 2022 Feb 16. pii: S0140-6736(21)02664.
    >> Share

  300. DINEEN K, Autzen B, Alwan NA
    Children, intersectionality, and COVID-19.
    Lancet. 2022 Feb 16. pii: S0140-6736(22)00174.
    >> Share


  301. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2022;399:665-676.
    >> Share

  302. EGGER S, Egger G
    The vaccinated propor-tion of people with COVID-19 needs context.
    Lancet. 2022;399:627.
    >> Share

  303. HORTON R
    Offline: Complacency threatens progress against COVID-19.
    Lancet. 2022;399:615.
    >> Share

  304. MUSSINI C, Cozzi-Lepri A
    Another piece in the COVID-19 treatment puzzle.
    Lancet. 2022;399:609-610.
    >> Share

  305. ADAMS LV, Dorough DS
    Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health.
    Lancet. 2022;399:613-614.
    >> Share

  306. LOPEZ A, Srigley J
    Transmission of SARS-CoV-2: still up in the air.
    Lancet. 2022;399:519.
    >> Share

  307. GREENHALGH T, Jimenez JL, Prather KA, Tufeki Z, et al
    Transmission of SARS-CoV-2: still up in the air - Authors' reply.
    Lancet. 2022;399:519-520.
    >> Share

  308. DALY M, Robinson E
    Depression and anxiety during COVID-19.
    Lancet. 2022;399:518.
    >> Share

  309. SANTOMAURO DF, Whiteford HA, Ferrari AJ
    Depression and anxiety during COVID-19 - Authors' reply.
    Lancet. 2022;399:518-519.
    >> Share

  310. SAMARASEKERA U
    Ayoade Alakija: advancing equity in the COVID-19 response.
    Lancet. 2022;399:511.
    >> Share

  311. ZAROCOSTAS J
    WHO concerned over COVID-19 health-care waste.
    Lancet. 2022;399:507.
    >> Share

  312. BURKI T
    Fresh questions over Gates Foundation governance.
    Lancet. 2022;399:508.
    >> Share

  313. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    >> Share

  314. THE LANCET
    Managing the opioid crisis in North America and beyond.
    Lancet. 2022;399:495.
    >> Share

  315. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    >> Share

  316. NORDSTROM P, Ballin M, Nordstrom A
    Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00089.
    >> Share

  317. KARAFILLAKIS E, Van Damme P, Hendrickx G, Larson HJ, et al
    COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
    Lancet. 2022 Feb 3. pii: S0140-6736(22)00150.
    >> Share


  318. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    Lancet. 2022 Feb 1. pii: S0140-6736(22)00172.
    >> Share

    January 2022
  319. HOLT E
    Polish Government COVID-19 advisors resign.
    Lancet. 2022;399:424.
    >> Share

  320. NEALON J, Cowling BJ
    Omicron severity: milder but not mild.
    Lancet. 2022;399:412-413.
    >> Share

  321. ADAMS R
    Urgent care: disability, pandemic, and the value of a life.
    Lancet. 2022;399:430-431.
    >> Share

  322. JAFFE S
    The next steps for US vaccine mandates.
    Lancet. 2022;399:425-426.
    >> Share

  323. SO-OSMAN C, Valk SJ
    High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00112.
    >> Share

  324. HUBSCHEN JM, Gouandjika-Vasilache I, Dina J
    Measles.
    Lancet. 2022 Jan 27. pii: S0140-6736(21)02004.
    >> Share


  325. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00101.
    >> Share

  326. FENDLER A, Shepherd STC, Au L, Wu M, et al
    Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00147.
    >> Share

  327. TANG TB
    The COVID-19 response in Hong Kong.
    Lancet. 2022;399:357.
    >> Share

  328. ALFIERI C, Egrot M, Desclaux A, Sams K, et al
    Recognising Italy's mistakes in the public health response to COVID-19.
    Lancet. 2022;399:357-358.
    >> Share

  329. BROWN K, Yahyouche A, Haroon S, Camaradou J, et al
    Long COVID and self-management.
    Lancet. 2022;399:355.
    >> Share

  330. HORTON R
    Offline: COVID-19 as culture war.
    Lancet. 2022;399:346.
    >> Share

  331. QURESHI I, Gogoi M, Al-Oraibi A, Wobi F, et al
    Intersectionality and developing evidence-based policy.
    Lancet. 2022;399:355-356.
    >> Share

  332. LANE R
    Jamal Rifi: family doctor building bridges in the community.
    Lancet. 2022;399:353.
    >> Share

  333. COSTA CLEMENS SA, Weckx L, Clemens R, Almeida Mendes AV, et al
    Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Lancet. 2022 Jan 21. pii: S0140-6736(22)00094.
    >> Share

  334. BRAVO L, Smolenov I, Han HH, Li P, et al
    Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00055.
    >> Share

  335. VESIKARI T
    Trimeric S protein COVID-19 vaccine needs to find its place.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00096.
    >> Share

  336. CARR EJ, Wu M, Harvey R, Billany RE, et al
    Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00104.
    >> Share

  337. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    >> Share

  338. MURRAY CJL
    COVID-19 will continue but the end of the pandemic is near.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00100.
    >> Share

  339. WU M, Wall EC, Carr EJ, Harvey R, et al
    Three-dose vaccination elicits neutralising antibodies against omicron.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00092.
    >> Share


  340. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Lancet. 2022 Jan 18. pii: S0140-6736(21)02724.
    >> Share

  341. KUHLMANN C, Mayer CK, Claassen M, Maponga T, et al
    Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00090.
    >> Share

  342. LAXMINARAYAN R
    The overlooked pandemic of antimicrobial resistance.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
    >> Share

  343. VALAIYAPATHI R, Wu MS, McGregor A
    Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin.
    Lancet. 2022;399:270.
    >> Share

  344. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    >> Share

  345. PUNTIS JWL
    The UK People's Covid Inquiry.
    Lancet. 2022;399:236.
    >> Share

  346. HARMAN S
    The wall.
    Lancet. 2022;399:136-137.
    >> Share

  347. BARBARO RP, MacLaren G, Swol J, Slutsky AS, et al
    COVID-19 ARDS: getting ventilation right - Authors' reply.
    Lancet. 2022;399:22-23.
    >> Share

  348. PEREZ-FERNANDEZ XL, Sabater-Riera J, Fuset-Cabanes M
    COVID-19 ARDS: getting ventilation right.
    Lancet. 2022;399:22.
    >> Share

  349. HESKIN J, Pallett SJC, Mughal N, Davies GW, et al
    Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.
    Lancet. 2022;399:21-22.
    >> Share

  350. THE LANCET
    The state of science and society in 2022.
    Lancet. 2022;399:1.
    >> Share

    December 2021
  351. KING J, Ferraz OLM, Jones A
    Mandatory COVID-19 vaccination and human rights.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02873.
    >> Share

  352. HALPERIN SA, Ye L, MacKinnon-Cameron D, Smith B, et al
    Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02753.
    >> Share

  353. KENNEDY RB
    Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02834.
    >> Share

  354. ORMISTON CK, Williams F
    LGBTQ youth mental health during COVID-19: unmet needs in public health and policy.
    Lancet. 2021 Dec 22. pii: S0140-6736(21)02872.
    >> Share

  355. LEUNG K, Wu JT
    Managing waning vaccine protection against SARS-CoV-2 variants.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02841.
    >> Share

  356. KATIKIREDDI SV, Cerqueira-Silva T, Vasileiou E, Robertson C, et al
    Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02754.
    >> Share

  357. PEELING RW, Heymann DL, Teo YY, Garcia PJ, et al
    Diagnostics for COVID-19: moving from pandemic response to control.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02346.
    >> Share

  358. DEJNIRATTISAI W, Shaw RH, Supasa P, Liu C, et al
    Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02844.
    >> Share

  359. HORTON R
    Offline: The lessons of smallpox eradication for COVID-19.
    Lancet. 2021;396:1951.
    >> Share

  360. THE LANCET
    Science during COVID-19: where do we go from here?
    Lancet. 2021;396:1941.
    >> Share

  361. FLEISHMAN R
    Dreams deferred.
    Lancet. 2021;396:2083-2084.
    >> Share

  362. DANIELS JP
    Caribbean rainy season batters health care.
    Lancet. 2021;396:1955.
    >> Share

  363. HALL V, Hopkins S
    COV-BOOST: evidence to support rapid booster deployment.
    Lancet. 2021;398:2209-2211.
    >> Share

  364. THE LANCET
    COVID-19: where do we go from here?
    Lancet. 2021;398:2207.
    >> Share

  365. MOLLICA RF, Fricchione GL
    Mental and physical exhaustion of health-care practitioners.
    Lancet. 2021;398:2243-2244.
    >> Share

  366. ZAROCOSTAS J
    WHO and World Bank urge spending for UHC.
    Lancet. 2021;398:2223.
    >> Share

  367. DEVI S
    Russia-Ukraine tensions hampering health-care access.
    Lancet. 2021;398:2222.
    >> Share

  368. COVIDSURG COLLABORATIVE
    Projecting COVID-19 disruption to elective surgery.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02836.
    >> Share

  369. MCINTYRE PB, Aggarwal R, Jani I, Jawad J, et al
    COVID-19 vaccine strategies must focus on severe disease and global equity.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02835.
    >> Share

  370. BRADBURY CA, McQuilten Z
    Anticoagulation in COVID-19.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02503.
    >> Share

  371. RAMACCIOTTI E, Barile Agati L, Calderaro D, Aguiar VCR, et al
    Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02392.
    >> Share

  372. LIPWORTH B, Chan R, Misirovs R
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2147.
    >> Share

  373. HOBBS FDR, Yu LM, Saville BR, Bafadhel M, et al
    High-dose budesonide for early COVID-19 - Authors' reply.
    Lancet. 2021;398:2147-2148.
    >> Share

  374. BEREZOWSKI I, Patel J, Shaw M, Pourmand A, et al
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2146-2147.
    >> Share

  375. SASO A, Skirrow H, Kampmann B
    Prioritising immunisation across the life course.
    Lancet. 2021;398:2145.
    >> Share

  376. THE LANCET
    Preventing violence against women: beyond 16 days.
    Lancet. 2021;398:2125.
    >> Share

  377. MOON S, Armstrong J, Hutler B, Upshur R, et al
    Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.
    Lancet. 2021 Dec 10. pii: S0140-6736(21)02344.
    >> Share

  378. STUART ASV, Shaw RH, Liu X, Greenland M, et al
    Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02718.
    >> Share

  379. RICHARDSON CD
    Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02757.
    >> Share

  380. EMANUEL EJ, Fabre C, Herzog L, Norheim OF, et al
    Obligations in a global health emergency - Authors' reply.
    Lancet. 2021;398:2072.
    >> Share

  381. DEVI S
    Health warnings over UNRWA funding shortfall.
    Lancet. 2021;398:2063.
    >> Share

  382. ZAROCOSTAS J
    Hope for nutrition summit as global hunger spikes.
    Lancet. 2021;398:2061-2062.
    >> Share

  383. WARD H, Flower B, Garcia PJ, Ong SWX, et al
    Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
    Lancet. 2021;398:2057-2059.
    >> Share

  384. KARIM SSA, Karim QA
    Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02758.
    >> Share

  385. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
    >> Share

  386. MUNRO APS, Janani L, Cornelius V, Aley PK, et al
    Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
    Lancet. 2021 Dec 2. pii: S0140-6736(21)02717.
    >> Share

    November 2021
  387. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
    >> Share

  388. CALDEIRA D, Pinto FJ
    COVID-19 and myocardial infarction.
    Lancet. 2021;398:1963-1964.
    >> Share

  389. BOUM Y
    Beyond COVID-19: scaling up and sustaining mobile health in Africa.
    Lancet. 2021;398:1962-1963.
    >> Share

  390. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.
    >> Share

  391. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    COVID-19 and myocardial infarction - Authors' reply.
    Lancet. 2021;398:1964.
    >> Share

  392. SAWADOGO NH, Sanou H, Greene JA, Duclos V, et al
    Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply.
    Lancet. 2021;398:1963.
    >> Share

  393. SMITH K, Brooks W, Challiner J, Povey E, et al
    Quality assurance of remote clinical assessments in the NHS.
    Lancet. 2021;398:1962.
    >> Share

  394. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    >> Share

  395. FLEMING KA, Horton S, Wilson ML, Atun R, et al
    The Lancet Commission on diagnostics: transforming access to diagnostics.
    Lancet. 2021;398:1997-2050.
    >> Share

  396. YANG C, Zhao H, Tebbutt SJ
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1872.
    >> Share

  397. HUANG L, Gu X, Cao B
    Long-term effects on survivors with COVID-19 - Authors' reply.
    Lancet. 2021;398:1872-1873.
    >> Share

  398. KAMPF G
    COVID-19: stigmatising the unvaccinated is not justified.
    Lancet. 2021;398:1871.
    >> Share

  399. ZHAO YJ, Bai W, Su Z, Ng CH, et al
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1871-1872.
    >> Share

  400. JAFFE S
    Legal challenges threaten Biden's COVID-19 vaccine rule.
    Lancet. 2021;398:1863-1864.
    >> Share

  401. KNEEBONE R, Houstoun W, Houghton N
    Medicine, magic, and online performance.
    Lancet. 2021;398:1868-1869.
    >> Share

  402. BURKI T
    mRNA discoveries earn the 2021 Prince Mahidol Award.
    Lancet. 2021;398:1865.
    >> Share


  403. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01825.
    >> Share

  404. SPYROPOULOS AC, Bonaca MP
    Studying the coagulopathy of COVID-19.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01906.
    >> Share

  405. OMER SB, Benjamin RM, Brewer NT, Buttenheim AM, et al
    Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02507.
    >> Share

  406. BHUTTA ZA, Salam RA, Gomber A, Lewis-Watts L, et al
    A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries.
    Lancet. 2021;398:1837-1850.
    >> Share

  407. PAVORD S, Scully M, Lester W, Makris M, et al
    Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine?
    Lancet. 2021;398:1801.
    >> Share

  408. BHUYAN P, Medin J, da Silva HG, Yadavalli M, et al
    Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors' reply.
    Lancet. 2021;398:1801-1802.
    >> Share

  409. LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
    Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
    >> Share

  410. ELLA R, Reddy S, Blackwelder W, Potdar V, et al
    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02000.
    >> Share

  411. LI JX, Zhu FC
    Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02014.
    >> Share

  412. SINGH S, McNab C, Olson RM, Bristol N, et al
    How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
    Lancet. 2021 Nov 8. pii: S0140-6736(21)01897.
    >> Share

  413. ALVES L
    Health experts welcome Brazil COVID-19 inquiry findings.
    Lancet. 2021;398:1674-1675.
    >> Share

  414. KICKBUSCH I, Piselli D, Agrawal A, Balicer R, et al
    The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world.
    Lancet. 2021;398:1727-1776.
    >> Share

  415. MCMULLEN AM
    The choice to love.
    Lancet. 2021;398:1680-1681.
    >> Share

  416. USHER AD
    New budget and strategy for ACT-A.
    Lancet. 2021;398:1677.
    >> Share

  417. ZAROCOSTAS J
    WHO's Tedros set to be re-elected unopposed.
    Lancet. 2021;398:1676.
    >> Share

  418. THE LANCET
    Can digital technologies improve health?
    Lancet. 2021;398:1663.
    >> Share

  419. ORTIZ JR, Neuzil KM
    The value of vaccine programme impact monitoring during the COVID-19 pandemic.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02322.
    >> Share

  420. MCNAMARA LA, Wiegand RE, Burke RM, Sharma AJ, et al
    Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02226.
    >> Share

    October 2021

  421. Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2021;398:1593-1618.
    >> Share

  422. GOLD C
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation.
    Lancet. 2021;398:1566.
    >> Share

  423. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
    Lancet. 2021;398:1566-1567.
    >> Share

  424. DANIELS JP
    Nicaraguan health-care workers under attack.
    Lancet. 2021;398:1555-1556.
    >> Share

  425. BAR-YAM Y, Gurdasani D, Baker MG, Scally G, et al
    The World Health Network: a global citizens' initiative.
    Lancet. 2021;398:1567-1568.
    >> Share

  426. HODGES S, Hornberger J, Kufakurinani U, Rudra S, et al
    When suspicion replaces evidence in public health.
    Lancet. 2021;398:1565-1566.
    >> Share

  427. BARDA N, Dagan N, Cohen C, Hernan MA, et al
    Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
    Lancet. 2021 Oct 29. pii: S0140-6736(21)02249.
    >> Share

  428. GRANGE Z, Buelo A, Sullivan C, Moore E, et al
    Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
    Lancet. 2021 Oct 28. pii: S0140-6736(21)02316.
    >> Share

  429. LEUNG GM
    Nowcasting towards sustainable SARS-CoV-2 endemicity.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02386.
    >> Share

  430. SONABEND R, Whittles LK, Imai N, Perez-Guzman PN, et al
    Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02276.
    >> Share

  431. XUE W, White A
    COVID-19 and the rebiologisation of racial difference.
    Lancet. 2021;398:1479-1480.
    >> Share

  432. MAKONI M
    African Medicines Agency to be established.
    Lancet. 2021;398:1475.
    >> Share

  433. USHER AD
    Vaccine shortages prompt changes to COVAX strategy.
    Lancet. 2021;398:1474.
    >> Share


  434. The Lancet Commission on water, sanitation and hygiene, and health.
    Lancet. 2021;398:1469-1470.
    >> Share

  435. RICCIARDI W, Tarricone R
    The evolution of the Italian National Health Service.
    Lancet. 2021 Oct 22. pii: S0140-6736(21)01733.
    >> Share

  436. HILLSON K, Clemens SC, Madhi SA, Voysey M, et al
    Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
    Lancet. 2021 Oct 21. pii: S0140-6736(21)02282.
    >> Share

  437. SAAG MS
    Developing COVID-19 vaccine policy in increments.
    Lancet. 2021;398:1382-1383.
    >> Share

  438. LOPES RD, de Barros E Silva PGM, Furtado RHM, Alexander JH, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
    Lancet. 2021;398:1304.
    >> Share

  439. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19.
    Lancet. 2021;398:1303-1304.
    >> Share

  440. MYERS SS, Pivor JI, Saraiva AM
    The Sao Paulo Declaration on Planetary Health.
    Lancet. 2021;398:1299.
    >> Share

  441. TAQUET M, Holmes EA, Harrison PJ
    Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02221.
    >> Share


  442. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02143.
    >> Share

  443. KOLA L, Kohrt BA, Acharya B, Mutamba BB, et al
    The path to global equity in mental health care in the context of COVID-19.
    Lancet. 2021 Oct 7. pii: S0140-6736(21)02233.
    >> Share

  444. KLEINERT S, Horton R
    Can COVID-19 help accelerate and transform the diagnostics agenda?
    Lancet. 2021 Oct 5. pii: S0140-6736(21)02093.
    >> Share

  445. PRENDECKI M, Thomson T, Clarke CL, Martin P, et al
    Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02096.
    >> Share

  446. DE FOO C, Grepin KA, Cook AR, Hsu LY, et al
    Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02186.
    >> Share

  447. TARTOF SY, Slezak JM, Fischer H, Hong V, et al
    Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02183.
    >> Share

  448. TORRES I, Profeta B, Machado CV, Artaza O, et al
    COVID-19 research in LMICs - Authors' reply.
    Lancet. 2021;398:1213.
    >> Share

  449. SISA I, Fornasini M, Teran E
    COVID-19 research in LMICs.
    Lancet. 2021;398:1212-1213.
    >> Share

  450. BARBARO RP, MacLaren G, Boonstra PS, Combes A, et al
    Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
    Lancet. 2021;398:1230-1238.
    >> Share

  451. VUYLSTEKE A
    ECMO in COVID-19: do not blame the tool.
    Lancet. 2021;398:1197-1199.
    >> Share

  452. VINER RM, Koirala A
    Daily antigen testing to reduce disruption when schools return.
    Lancet. 2021;398:1196-1197.
    >> Share

    September 2021
  453. PINTO FJ, Pineiro D, Banerjee A, Perel P, et al
    World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease.
    Lancet. 2021 Sep 28. pii: S0140-6736(21)02144.
    >> Share

  454. THE LANCET
    COVID-19: learning as an interdependent world.
    Lancet. 2021;398:1105.
    >> Share

  455. AAVITSLAND P, Aguilera X, Al-Abri SS, Amani V, et al
    Functioning of the International Health Regulations during the COVID-19 pandemic.
    Lancet. 2021 Sep 24. pii: S0140-6736(21)01911.
    >> Share

  456. OGBUOJI O, Mao W, Aryeetey G
    The long-term impact of COVID-19 on development assistance for health is still uncertain.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01448.
    >> Share


  457. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01258.
    >> Share

  458. WU Z, Jin Q, Wu G, Lu J, et al
    SARS-CoV-2's origin should be investigated worldwide for pandemic prevention.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02020.
    >> Share

  459. VAN HELDEN J, Butler CD, Achaz G, Canard B, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02019.
    >> Share

  460. KEUSCH GT, Lam SK, Mackenzie JS, Saif L, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02013.
    >> Share

  461. SHARFSTEIN JM, Callaghan T, Carpiano RM, Sgaier SK, et al
    Uncoupling vaccination from politics: a call to action.
    Lancet. 2021 Sep 16. pii: S0140-6736(21)02099.
    >> Share

  462. YOUNG BC, Eyre DW, Kendrick S, White C, et al
    Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)01908.
    >> Share

  463. KRAUSE PR, Fleming TR, Peto R, Longini IM, et al
    Considerations in boosting COVID-19 vaccine immune responses.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)02046.
    >> Share

  464. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.
    >> Share

  465. DANIELS JP
    Earthquake compounds Haiti's health challenges.
    Lancet. 2021;398:944-945.
    >> Share

  466. MONTI M, Torbica A, Mossialos E, McKee M, et al
    A new strategy for health and sustainable development in the light of the COVID-19 pandemic.
    Lancet. 2021 Sep 9. pii: S0140-6736(21)01995.
    >> Share

  467. HARVEY SB, Epstein RM, Glozier N, Petrie K, et al
    Mental illness and suicide among physicians.
    Lancet. 2021;398:920-930.
    >> Share

  468. BOSELEY S
    The race to make a COVID-19 vaccine.
    Lancet. 2021;398:832-833.
    >> Share

  469. JERVING S
    The long road ahead for COVID-19 vaccination in Africa.
    Lancet. 2021;398:827-828.
    >> Share

  470. GAMALLIEL N, Saminarsih D, Taher A
    Indonesia's second wave crisis: medical doctors' political role is needed more than ever.
    Lancet. 2021;398:839-840.
    >> Share

  471. ROGAWSKI MCQUADE ET, Breskin A
    Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01817.
    >> Share

  472. KASEJE N, Walcott D
    Global youth advocating for COVID-19 vaccines for all.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01994.
    >> Share

  473. FLAXMAN A, Marchevsky NG, Jenkin D, Aboagye J, et al
    Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01699.
    >> Share

    August 2021
  474. HUANG L, Yao Q, Gu X, Wang Q, et al
    1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Lancet. 2021;398:747-758.
    >> Share

  475. THE LANCET
    Understanding long COVID: a modern medical challenge.
    Lancet. 2021;398:725.
    >> Share

  476. LANGLOIS EV, Dey T, Shah MG
    More than honour, humanitarian health-care workers need life-saving protection.
    Lancet. 2021;398:729-730.
    >> Share

  477. ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
    The costs of PEPFAR's leadership vacuum.
    Lancet. 2021;398:741.
    >> Share

  478. LINDENFELD J, Zile MR, Desai AS, Bhatt K, et al
    Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01754.
    >> Share

  479. SOAR J, Becker LB, Berg KM, Einav S, et al
    Cardiopulmonary resuscitation in special circumstances.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01257.
    >> Share

  480. SALLES A, Jagsi R
    Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic.
    Lancet. 2021 Aug 24. pii: S0140-6736(21)01912.
    >> Share

  481. CONLY J, Chou R, Schwaber MJ, Voss A, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660.
    >> Share

  482. JUNI P, da Costa BR, Bobos P, Bodmer NS, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:663.
    >> Share

  483. CHU D, Khamis A, Akl E, Neumann I, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection - Authors' reply.
    Lancet. 2021;398:663-664.
    >> Share

  484. ZHOU Q, Wang X, Estill J, Yang K, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661.
    >> Share

  485. ABBAS M, Goto M, Tartari E, Perencevich E, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661-663.
    >> Share

  486. SCORRANO L, Baglivo I, Cavallo DM, Cecconi F, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660-661.
    >> Share

  487. LIJFERING WM
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:659-660.
    >> Share

  488. COGHLAN R
    Broaden the narrative this World Humanitarian Day: honour those who comfort the dying.
    Lancet. 2021;398:659.
    >> Share

  489. ROCHON PA, Kalia S, Higgs P
    Gendered ageism: addressing discrimination based on age and sex.
    Lancet. 2021;398:648-649.
    >> Share

  490. ADEPOJU P
    West Africa on alert for haemorrhagic fevers.
    Lancet. 2021;398:653.
    >> Share

  491. USHER AD
    Health leaders criticise limited ACT-A review.
    Lancet. 2021;398:650-651.
    >> Share

  492. BEHRENS GM, Cossmann A, Stankov MV, Nehlmeier I, et al
    SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01891.
    >> Share


  493. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01207.
    >> Share

  494. THORNTON J
    Focusing on island health.
    Lancet. 2021;398:569-570.
    >> Share

  495. DANIELS JP
    Haiti's health woes intensify.
    Lancet. 2021;398:567.
    >> Share

  496. FRIEDEN TR, Lee CT, Bochner AF, Buissonniere M, et al
    7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics.
    Lancet. 2021;398:638-640.
    >> Share

  497. BHUYAN P, Medin J, da Silva HG, Yadavalli M, et al
    Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis.
    Lancet. 2021;398:577-578.
    >> Share

  498. BEHAGUE D, Ortega F
    Mutual aid, pandemic politics, and global social medicine in Brazil.
    Lancet. 2021;398:575-576.
    >> Share

  499. READ JM, Green CA, Harrison EM, Docherty AB, et al
    Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01786.
    >> Share

  500. CARR EJ, Wu M, Harvey R, Wall EC, et al
    Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01854.
    >> Share

  501. ETIENNE CF
    Tackling Latin America's COVID-19 emergency requires greater solidarity.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01757.
    >> Share

  502. KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
    SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
    >> Share

  503. LLOYD-SHERLOCK P, Lasco G, McKee M, Perianayagam A, et al
    Does vaccine ageism amount to gerontocide?
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01689.
    >> Share

  504. PUNG R, Mak TM, Kucharski AJ, Lee VJ, et al
    Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01697.
    >> Share

  505. MANGIN D, Howard M
    The use of inhaled corticosteroids in early-stage COVID-19.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01809.
    >> Share

  506. YU LM, Bafadhel M, Dorward J, Hayward G, et al
    Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01744.
    >> Share

  507. PRIESEMANN V, Balling R, Bauer S, Beutels P, et al
    Towards a European strategy to address the COVID-19 pandemic.
    Lancet. 2021 Aug 9. pii: S0140-6736(21)01808.
    >> Share

  508. BICCARD BM, Thomson D, Miller M, Taylor EH, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
    Lancet. 2021;398:486-487.
    >> Share

  509. PISANI L, Waweru-Siika W, Sendagire C, Beane A, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data.
    Lancet. 2021;398:485-486.
    >> Share

  510. DOLEZAL L, Rose A, Cooper F
    COVID-19, online shaming, and health-care professionals.
    Lancet. 2021;398:482-483.
    >> Share

  511. LEE N
    Lucy Chappell: setting the agenda for UK research policy.
    Lancet. 2021;398:481.
    >> Share

  512. DEVI S
    Mediterranean migrants lacking health care.
    Lancet. 2021;398:479-480.
    >> Share

  513. BLACK C
    Treatment for drug dependence in England needs investment and reform.
    Lancet. 2021;398:474-476.
    >> Share

  514. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    >> Share

  515. PERRY RJ, Tamborska A, Singh B, Craven B, et al
    Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01608.
    >> Share

  516. LIU X, Shaw RH, Stuart ASV, Greenland M, et al
    Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01694.
    >> Share

  517. BELDA-INIESTA C
    Optimising SARS-CoV-2 vaccination schedules.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01729.
    >> Share

  518. EMANUEL EJ, Buchanan A, Chan SY, Fabre C, et al
    What are the obligations of pharmaceutical companies in a global health emergency?
    Lancet. 2021 Aug 5. pii: S0140-6736(21)01378.
    >> Share

  519. CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
    Mucormycosis after COVID-19 in a patient with diabetes.
    Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.
    >> Share

    July 2021
  520. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    >> Share

  521. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    >> Share

  522. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    >> Share

  523. SHROTRI M, Navaratnam AMD, Nguyen V, Byrne T, et al
    Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.
    Lancet. 2021;398:385-387.
    >> Share

  524. THE LANCET
    A sporting chance: physical activity as part of everyday life.
    Lancet. 2021;398:365.
    >> Share

  525. KAMPMANN B, Okomo U
    COVID-19 vaccines for children in LMICs: another equity issue.
    Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
    >> Share

  526. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
    Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
    >> Share

  527. MAFHAM M, Baigent C
    What is the association of COVID-19 with heart attacks and strokes?
    Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.
    >> Share

  528. HORBY P, Staplin N, Haynes R, Landray M, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
    Lancet. 2021;398:300.
    >> Share

  529. YANG C, Zhao H
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299.
    >> Share

  530. NEUMANN AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299-300.
    >> Share

  531. MARKS L
    Past and present women pioneers in biomedical science.
    Lancet. 2021;398:293-295.
    >> Share

  532. MAKONI M
    Social unrest disrupts South African health care.
    Lancet. 2021;398:287.
    >> Share

  533. REDJOUL R, Le Bouter A, Beckerich F, Fourati S, et al
    Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
    Lancet. 2021;398:298-299.
    >> Share

  534. THE LANCET
    A time of crisis for the opioid epidemic in the USA.
    Lancet. 2021;398:277.
    >> Share

  535. JAUREGUI A, Lambert EV, Panter J, Moore C, et al
    Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond.
    Lancet. 2021 Jul 21. pii: S0140-6736(21)01599.
    >> Share

  536. HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
    Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
    >> Share

  537. KENTOR RA, Thompson AL
    Answering the call to support youth orphaned by COVID-19.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01446.
    >> Share

  538. DRAKE TM, Riad AM, Fairfield CJ, Egan C, et al
    Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Lancet. 2021;398:223-237.
    >> Share

  539. HARGREAVES S, Hayward SE, Noori T, McKee M, et al
    COVID-19: counting migrants in.
    Lancet. 2021;398:211-212.
    >> Share

  540. GU X, Cao B
    In-hospital complications associated with COVID-19.
    Lancet. 2021;398:188-190.
    >> Share

  541. THE LANCET
    COVID-19 in Africa: a lesson in solidarity.
    Lancet. 2021;398:185.
    >> Share

  542. IDROVO AJ
    More social discontent than pandemic-related risk perception in Colombia.
    Lancet. 2021;398:211.
    >> Share

  543. FISSEHA S, Sen G, Ghebreyesus TA, Byanyima W, et al
    COVID-19: the turning point for gender equality.
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01651.
    >> Share

  544. HIAM L, Yates R
    Will the COVID-19 crisis catalyse universal health reforms?
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01650.
    >> Share

  545. CAUCHEMEZ S, Bosetti P, Kiem CT, Mouro V, et al
    Education and mental health: good reasons to vaccinate children.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01453.
    >> Share

  546. CAUSEY K, Fullman N, Sorensen RJD, Galles NC, et al
    Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01337.
    >> Share


  547. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)00984.
    >> Share

  548. ABBAS K, Mogasale V
    Disruptions to childhood immunisation due to the COVID-19 pandemic.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01418.
    >> Share

  549. THE LANCET
    COVID-19 in Latin America-emergency and opportunity.
    Lancet. 2021;398:93.
    >> Share

  550. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    WHO COVID-19 therapeutic guidelines - Authors' reply.
    Lancet. 2021;398:118.
    >> Share

  551. ROCHWERG B, Agoritsas T, Diaz J, Askie L, et al
    WHO COVID-19 therapeutic guidelines.
    Lancet. 2021;398:117-118.
    >> Share

  552. ALSABA K
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region.
    Lancet. 2021;398:116.
    >> Share

  553. NABETH P, Hassan M, Adib K, Abubakar A, et al
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply.
    Lancet. 2021;398:116-117.
    >> Share

  554. GARDNER C, Kleinman A
    Medicine and the unconscious.
    Lancet. 2021;398:112-113.
    >> Share

  555. LEHTIMAKI S, Allotey P, Schwalbe N
    Pandemic response requires early and robust verification.
    Lancet. 2021;398:115.
    >> Share

  556. TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
    Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
    Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
    >> Share

  557. GURDASANI D, Drury J, Greenhalgh T, Griffin S, et al
    Mass infection is not an option: we must do more to protect our young.
    Lancet. 2021 Jul 7. pii: S0140-6736(21)01589.
    >> Share

  558. CALISHER CH, Carroll D, Colwell R, Corley RB, et al
    Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.
    Lancet. 2021 Jul 5. pii: S0140-6736(21)01419.
    >> Share

  559. PALMER KR, Tanner M, Davies-Tuck M, Rindt A, et al
    Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2021;398:41-52.
    >> Share

  560. CLARKE R
    Sparks through the stubble: dying in a pandemic.
    Lancet. 2021;398:18-19.
    >> Share

  561. THORNTON J
    Levelling up health in the UK.
    Lancet. 2021;398:14-15.
    >> Share

  562. DEVI S
    North Korean health at risk due to border closures.
    Lancet. 2021;398:13.
    >> Share

  563. THE LANCET
    Germany's election: transformation versus more of the same.
    Lancet. 2021;398:1.
    >> Share

  564. KICKBUSCH I, Leung GM, Shattock RJ
    Learning from crisis: building resilient systems to combat future pandemics.
    Lancet. 2021;398:e2-e6.
    >> Share

  565. MEYER NJ, Gattinoni L, Calfee CS
    Acute respiratory distress syndrome.
    Lancet. 2021 Jul 1. pii: S0140-6736(21)00439.
    >> Share

    June 2021
  566. WALL EC, Wu M, Harvey R, Kelly G, et al
    AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
    Lancet. 2021 Jun 28. pii: S0140-6736(21)01462.
    >> Share

  567. KUMAR D, Mittal M
    India's COVID-19 emergency: overarching conclusions belie facts.
    Lancet. 2021;397:2465.
    >> Share

  568. SAHA K
    Can India's COVID-19 emergency be fixed without politics?
    Lancet. 2021;397:2465-2466.
    >> Share

  569. VISARIA A, Dharamdasani T
    The complex causes of India's 2021 COVID-19 surge.
    Lancet. 2021;397:2464.
    >> Share

  570. RADHAKRISHNAN N, Gupta DK
    India's COVID-19 response: science first.
    Lancet. 2021;397:2464-2465.
    >> Share

  571. DUTTA R, Kucchal T
    India's pain: beyond COVID-19 case numbers and mortality rates.
    Lancet. 2021;397:2463.
    >> Share

  572. DANIELS JP
    Colombians protest over inequities and health care.
    Lancet. 2021;397:2454.
    >> Share

  573. SMITH MJ
    What constitutes success in the roll-out of COVID-19 vaccines?
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01244.
    >> Share

  574. DUARTE-SALLES T, Prieto-Alhambra D
    Heterologous vaccine regimens against COVID-19.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01442.
    >> Share

  575. BOROBIA AM, Carcas AJ, Perez-Olmeda M, Castano L, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01420.
    >> Share

  576. THE LANCET
    Protecting refugees during the COVID-19 pandemic.
    Lancet. 2021;397:2309.
    >> Share

  577. BARRON GC, Koonin J
    A call to action on UHC commitments.
    Lancet. 2021;397:2335-2336.
    >> Share

  578. USHER AD
    A beautiful idea: how COVAX has fallen short.
    Lancet. 2021;397:2322-2325.
    >> Share

  579. KC S, Ananthakrishnan A, Painter C, Butani D, et al
    Research collaboration is needed to inform quarantine policies for health-care workers.
    Lancet. 2021;397:2334.
    >> Share

  580. ABECASSIS A
    Five priorities for universal COVID-19 vaccination.
    Lancet. 2021 Jun 17. pii: S0140-6736(21)01371.
    >> Share

  581. SHEIKH A, McMenamin J, Taylor B, Robertson C, et al
    SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.
    Lancet. 2021 Jun 14. pii: S0140-6736(21)01358.
    >> Share

  582. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Lancet. 2021;397:2249-2250.
    >> Share

  583. ROBERTSON JFR, Sewell HF
    COVID-19 vaccine efficacy data: solid enough to delay second dose?
    Lancet. 2021;397:2248-2249.
    >> Share

  584. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Lancet. 2021;397:2248.
    >> Share

  585. MCQUADE ETR, Platts-Mills JA
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates.
    Lancet. 2021;397:2247-2248.
    >> Share

  586. NASSER A, Zakham F
    A strategy for SARS-CoV-2 vaccination in Yemen.
    Lancet. 2021;397:2247.
    >> Share

  587. GUBRIUM A, Gubrium E
    Narrative complexity in the time of COVID-19.
    Lancet. 2021;397:2244-2245.
    >> Share

  588. BERGER JS, Connors JM
    Anticoagulation in COVID-19: reaction to the ACTION trial.
    Lancet. 2021;397:2226-2228.
    >> Share

  589. MCLELLAN F
    Kirsten Ostherr: mobilising the translational humanities.
    Lancet. 2021;397:2243.
    >> Share

  590. THE LANCET
    We need a global conversation on the 2020 Olympic Games.
    Lancet. 2021;397:2225.
    >> Share

  591. GUETL K, Gary T, Raggam RB, Schmid J, et al
    SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
    Lancet. 2021 Jun 11. pii: S0140-6736(21)01238.
    >> Share

  592. EVAGORA-CAMPBELL M, Borkotoky K, Sharma S, Mbuthia M, et al
    From routine data collection to policy design: sex and gender both matter in COVID-19.
    Lancet. 2021 Jun 10. pii: S0140-6736(21)01326.
    >> Share

  593. BOLLYKY TJ, Murray CJL, Reiner RC Jr
    Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
    Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
    >> Share

  594. KUMAR A, Bernasconi V, Manak M, de Almeida Aranha AP, et al
    The CEPI centralised laboratory network: supporting COVID-19 vaccine development.
    Lancet. 2021;397:2148-2149.
    >> Share

  595. ZAROCOSTAS J
    Aid agencies escalate Gaza relief effort.
    Lancet. 2021;397:2136.
    >> Share

  596. BEYRER C
    A pandemic anniversary: 40 years of HIV/AIDS.
    Lancet. 2021;397:2142-2143.
    >> Share

  597. SHROFF ZC, Marten R, Vega J, Peters DH, et al
    Time to reconceptualise health systems.
    Lancet. 2021;397:2145.
    >> Share

  598. USHER AD
    ACT Accelerator strains donors' aid budgets.
    Lancet. 2021;397:2137.
    >> Share

  599. CHAN EYY, Gobat N, Dubois C, Bedson J, et al
    Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01233.
    >> Share

  600. LOPES RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, et al
    Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01203.
    >> Share

  601. WALL EC, Wu M, Harvey R, Kelly G, et al
    Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
    Lancet. 2021 Jun 3. pii: S0140-6736(21)01290.
    >> Share

  602. KOSAKA M, Hashimoto T, Ozaki A, Tanimoto T, et al
    Delayed COVID-19 vaccine roll-out in Japan.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01220.
    >> Share

  603. NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
    Tackling missed opportunities for vaccination in a new era of immunisation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
    >> Share

  604. FORMAN R, Jit M, Mossialos E
    Divergent vaccination policies could fuel mistrust and hesitancy.
    Lancet. 2021 Jun 1. pii: S0140-6736(21)01106.
    >> Share

    May 2021
  605. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    >> Share

  606. TATUM M
    Cambodia ends controversial COVID-19 restrictions.
    Lancet. 2021;397:2035.
    >> Share

  607. DEVI S
    Yemen's health system has "collapsed", warns UN.
    Lancet. 2021;397:2036.
    >> Share

  608. DEVI S
    800 000 South Sudanese to lose access to health care.
    Lancet. 2021;397:2034.
    >> Share

  609. AIYAR Y, Chandru V, Chatterjee M, Desai S, et al
    India's resurgence of COVID-19: urgent actions needed.
    Lancet. 2021 May 25. pii: S0140-6736(21)01202.
    >> Share


  610. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
    Lancet. 2021;397:1885-1894.
    >> Share

  611. JAWAD NK, Taweeleh LA, Elharake JA, Khamis N, et al
    Refugee access to COVID-19 vaccines in Lebanon.
    Lancet. 2021;397:1884.
    >> Share

  612. NESAMONEY SN, Darmstadt GL, Wise PH
    Gendered effects of COVID-19 on young girls in regions of conflict.
    Lancet. 2021;397:1880-1881.
    >> Share

  613. ZAROCOSTAS J
    What next for a COVID-19 intellectual property waiver?
    Lancet. 2021;397:1871-1872.
    >> Share

  614. KIRENGA BJ, Byakika-Kibwika P
    Excess COVID-19 mortality among critically ill patients in Africa.
    Lancet. 2021;397:1860-1861.
    >> Share

  615. MCGEORGE E, James J, Abraham N
    The intergenerational project: creating space for play in health care.
    Lancet. 2021;397:1876-1877.
    >> Share

  616. SAMARASEKERA U
    Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
    Lancet. 2021;397:1873.
    >> Share

  617. HUANG L, Gu X, Wang Y, Huang C, et al
    Long-term effects of COVID-19 on kidney function - Authors' reply.
    Lancet. 2021;397:1807-1808.
    >> Share

  618. LOYO ESL, Gonzalez MJ, Esparza J
    Venezuela is collapsing without COVID-19 vaccines.
    Lancet. 2021;397:1806.
    >> Share

  619. WATSON SI
    Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
    Lancet. 2021;397:1804-1805.
    >> Share

  620. GENC K
    COVID-19 in Turkey: a nation on edge.
    Lancet. 2021;397:1794-1796.
    >> Share

  621. DELANAYE P, Huart J, Bouquegneau A, Jouret F, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1807.
    >> Share

  622. ENGHARD P, Hardenberg JH, Stockmann H, Hinze C, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1806-1807.
    >> Share

  623. HOUSTON AR, Murthy S
    Canada is no global health leader on COVID-19 vaccine equity.
    Lancet. 2021;397:1803.
    >> Share

  624. HOLT E
    Serbia begins paying citizens to receive a COVID-19 vaccine.
    Lancet. 2021;397:1793.
    >> Share

  625. WENHAM C, Kavanagh M, Phelan A, Rushton S, et al
    Problems with traffic light approaches to public health emergencies of international concern.
    Lancet. 2021;397:1856-1858.
    >> Share

  626. HIMMELSTEIN DU, Woolhandler S
    Recovering from Trump: Biden's first 100 days.
    Lancet. 2021;397:1787-1791.
    >> Share

  627. MORGAN OW, Aguilera X, Ammon A, Amuasi J, et al
    Disease surveillance for the COVID-19 era: time for bold changes.
    Lancet. 2021 May 14. pii: S0140-6736(21)01096.
    >> Share


  628. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00897.
    >> Share

  629. KUPPALLI K, Gala P, Cherabuddi K, Kalantri SP, et al
    India's COVID-19 crisis: a call for international action.
    Lancet. 2021 May 14. pii: S0140-6736(21)01121.
    >> Share

  630. LIU STH, Aberg JA
    Convalescent plasma in patients hospitalised with COVID-19.
    Lancet. 2021 May 14. pii: S0140-6736(21)01064.
    >> Share

  631. JHA P, Jamison DT, Watkins DA, Bell J, et al
    A global compact to counter vaccine nationalism.
    Lancet. 2021 May 14. pii: S0140-6736(21)01105.
    >> Share

  632. SHAW RH, Stuart A, Greenland M, Liu X, et al
    Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
    Lancet. 2021 May 12. pii: S0140-6736(21)01115.
    >> Share

  633. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV
    Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
    Lancet. 2021 May 12. pii: S0140-6736(21)00894.
    >> Share

  634. SIRLEAF EJ, Clark H
    Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic.
    Lancet. 2021 May 11. pii: S0140-6736(21)01095.
    >> Share

  635. MATHUR R, Rentsch CT, Morton CE, Hulme WJ, et al
    Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
    Lancet. 2021;397:1711-1724.
    >> Share

  636. MORALES DR, Ali SN
    COVID-19 and disparities affecting ethnic minorities.
    Lancet. 2021;397:1684-1685.
    >> Share

  637. FUJIWARA Y, Onda Y, Hayashi S
    No-fault compensation schemes for COVID-19 medical products.
    Lancet. 2021;397:1707-1708.
    >> Share

  638. SHAH W, Heightman M, O'Brien S
    UK guidelines for managing long-term effects of COVID-19.
    Lancet. 2021;397:1706.
    >> Share

  639. THE LANCET
    India's COVID-19 emergency.
    Lancet. 2021;397:1683.
    >> Share

  640. HE S, Bala R, Anupindi R, Ranney ML, et al
    Effective supply chain surveillance for PPE.
    Lancet. 2021;397:1706-1707.
    >> Share

  641. DEVI S
    COVID-19 surge threatens health in the Gaza strip.
    Lancet. 2021;397:1698.
    >> Share

  642. SAXENA SG, Godfrey T
    Catalysing needed change for health systems in the USA.
    Lancet. 2021;397:1705-1706.
    >> Share

  643. NASAR S
    Patrolling race and the UK's medical borders.
    Lancet. 2021;397:1702-1703.
    >> Share

  644. ZAROCOSTAS J
    UK makes massive global health cuts.
    Lancet. 2021;397:1697.
    >> Share

  645. HOLT E
    Media restrictions have "cost lives".
    Lancet. 2021;397:1695-1696.
    >> Share

  646. RICHTER L, Ghent L, Issa G, Okengo L, et al
    What the ODA cuts mean for us.
    Lancet. 2021;397:1705.
    >> Share

  647. REINHART E, Dawes D, Maybank A
    Structural medicine: towards an economy of care.
    Lancet. 2021;397:1691-1693.
    >> Share

  648. KIDD SA, Hajat S, Bezgrebelna M, McKenzie K, et al
    The climate change-homelessness nexus.
    Lancet. 2021;397:1693-1694.
    >> Share


  649. Priorities for COVID-19 research response and preparedness in low-resource settings.
    Lancet. 2021 May 6. pii: S0140-6736(21)00980.
    >> Share

  650. MCKEE M, Dunnell K, Anderson M, Brayne C, et al
    The changing health needs of the UK population.
    Lancet. 2021 May 6. pii: S0140-6736(21)00229.
    >> Share

  651. ANDERSON M, Pitchforth E, Asaria M, Brayne C, et al
    LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19.
    Lancet. 2021 May 6. pii: S0140-6736(21)00232.
    >> Share

  652. CHARLESWORTH A, Anderson M, Donaldson C, Johnson P, et al
    What is the right level of spending needed for health and care in the UK?
    Lancet. 2021 May 6. pii: S0140-6736(21)00230.
    >> Share

  653. ANDERSON M, O'Neill C, Macleod Clark J, Street A, et al
    Securing a sustainable and fit-for-purpose UK health and care workforce.
    Lancet. 2021 May 6. pii: S0140-6736(21)00231.
    >> Share

  654. HAAS EJ, Angulo FJ, McLaughlin JM, Anis E, et al
    Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Lancet. 2021 May 5. pii: S0140-6736(21)00947.
    >> Share

  655. LESHEM E, Wilder-Smith A
    COVID-19 vaccine impact in Israel and a way out of the pandemic.
    Lancet. 2021 May 5. pii: S0140-6736(21)01018.
    >> Share


  656. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021;397:1637-1645.
    >> Share

  657. BHUYAN A
    Experts criticise India's complacency over COVID-19.
    Lancet. 2021;397:1611-1612.
    >> Share

  658. GUPTA S, Leaf DE
    Tocilizumab in COVID-19: some clarity amid controversy.
    Lancet. 2021;397:1599-1601.
    >> Share

  659. FOGSTAD H
    Women, children, and adolescents in the post-pandemic world.
    Lancet. 2021;397:1620.
    >> Share

  660. HYDE R
    Controversy surrounds Merkel's new lockdown powers.
    Lancet. 2021;397:1610.
    >> Share

    April 2021
  661. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.
    Lancet. 2021 Apr 28. pii: S0140-6736(21)00978.
    >> Share

  662. MAGNAVITA N, Chirico F, Sacco A
    COVID-19: from hospitals to courts.
    Lancet. 2021;397:1542.
    >> Share

  663. USUELLI M
    COVID-19: from hospitals to courts - Author's reply.
    Lancet. 2021;397:1542.
    >> Share

  664. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
    Lancet. 2021;397:1541.
    >> Share

  665. KRUGER C
    Call for a pan-European COVID-19 response must be comprehensive.
    Lancet. 2021;397:1540-1541.
    >> Share

  666. BURKI T
    Statelessness in the COVID-19 pandemic.
    Lancet. 2021;397:1529-1530.
    >> Share

  667. THE LANCET
    2021: the beginning of a new era of immunisations?
    Lancet. 2021;397:1519.
    >> Share

  668. MARMOT M, Al-Mandhari A, Ghaffar A, El-Adawy M, et al
    Build back fairer: achieving health equity in the Eastern Mediterranean region of WHO.
    Lancet. 2021;397:1527-1528.
    >> Share

  669. RASANATHAN K
    Global health and its discontents.
    Lancet. 2021;397:1543-1544.
    >> Share

  670. HALL VJ, Foulkes S, Saei A, Andrews N, et al
    COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00790.
    >> Share

  671. DEAN N
    Hospital admissions due to COVID-19 in Scotland after one dose of vaccine.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00765.
    >> Share

  672. VASILEIOU E, Simpson CR, Shi T, Kerr S, et al
    Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00677.
    >> Share

  673. KHAN MS, Ali SAM, Adelaine A, Karan A, et al
    Rethinking vaccine hesitancy among minority groups.
    Lancet. 2021 Apr 21. pii: S0140-6736(21)00938.
    >> Share

  674. CLAESON M, Hanson S
    The Swedish COVID-19 strategy revisited.
    Lancet. 2021 Apr 19. pii: S0140-6736(21)00885.
    >> Share

  675. ALVES L
    Brazilian ICUs short of drugs and beds amid COVID-19 surge.
    Lancet. 2021;397:1431-1432.
    >> Share

  676. STOEKLE HC, Ivasilevitch A, Herve C
    COVID-19: time for ethical reflection?
    Lancet. 2021 Apr 16. pii: S0140-6736(21)00795.
    >> Share

  677. GREENHALGH T, Jimenez JL, Prather KA, Tufekci Z, et al
    Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
    Lancet. 2021 Apr 15. pii: S0140-6736(21)00869.
    >> Share

  678. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    >> Share

  679. BAYAS A, Menacher M, Christ M, Behrens L, et al
    Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00872.
    >> Share

  680. MFINANGA SG, Mnyambwa NP, Minja DT, Ntinginya NE, et al
    Tanzania's position on the COVID-19 pandemic.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00678.
    >> Share

  681. MUSTER V, Gary T, Raggam RB, WOlfler A, et al
    Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00871.
    >> Share

  682. ZAROCOSTAS J
    Calls for transparency after SARS-CoV-2 origins report.
    Lancet. 2021;397:1335.
    >> Share

  683. THE LANCET
    China's response to COVID-19: a chance for collaboration.
    Lancet. 2021;397:1325.
    >> Share

  684. CAPUA I, Giaquinto C
    The unsung virtue of thermostability.
    Lancet. 2021;397:1346.
    >> Share

  685. CASSAN J, Claude A, de Hillerin M, Fontaine A, et al
    The ultra-connected generation would like to disconnect now.
    Lancet. 2021;397:1350.
    >> Share

  686. ANDREWS K
    Racism is the public health crisis.
    Lancet. 2021;397:1342-1343.
    >> Share

  687. KRAMMER F
    Correlates of protection from SARS-CoV-2 infection.
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00782.
    >> Share

  688. HALL VJ, Foulkes S, Charlett A, Atti A, et al
    SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00675.
    >> Share

  689. LI L, Wang K, Chen Z, Koplan JP, et al
    US-China health exchange and collaboration following COVID-19.
    Lancet. 2021 Apr 8. pii: S0140-6736(21)00734.
    >> Share

  690. ALI SN, Hanif W, Patel K, Khunti K, et al
    Ramadan and COVID-19 vaccine hesitancy-a call for action.
    Lancet. 2021 Apr 7. pii: S0140-6736(21)00779.
    >> Share

  691. SALYER SJ, Maeda J, Sembuche S, Kebede Y, et al
    The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Lancet. 2021;397:1265-1275.
    >> Share

  692. LOTTA G, Fernandez M, Pimenta D, Wenham C, et al
    Gender, race, and health workers in the COVID-19 pandemic.
    Lancet. 2021;397:1264.
    >> Share

  693. BOUM Y, Bebell LM, Bisseck AZ
    Africa needs local solutions to face the COVID-19 pandemic.
    Lancet. 2021;397:1238-1240.
    >> Share

  694. WONG CHUNG JERE, Engin O, Wolfs TFW, Renson TJC, et al
    Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
    Lancet. 2021;397:e10.
    >> Share

  695. BOJORQUEZ I, Cabieses B, Arosquipa C, Arroyo J, et al
    Migration and health in Latin America during the COVID-19 pandemic and beyond.
    Lancet. 2021;397:1243-1245.
    >> Share

  696. HE S, Lai D, Lee J
    The medical right to repair: the right to save lives.
    Lancet. 2021;397:1260-1261.
    >> Share

  697. SAMARASEKERA U
    New EU health programme comes into force.
    Lancet. 2021;397:1252-1253.
    >> Share

  698. JABBOUR S, Leaning J, Nuwayhid I, Ager A, et al
    10 years of the Syrian conflict: a time to act and not merely to remember.
    Lancet. 2021;397:1245-1248.
    >> Share

  699. D'SOUZA RS, Wolfe I
    COVID-19 vaccines in high-risk ethnic groups.
    Lancet. 2021 Apr 1. pii: S0140-6736(21)00624.
    >> Share

    March 2021
  700. EMARY KRW, Golubchik T, Aley PK, Ariani CV, et al
    Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00628.
    >> Share

  701. OSTERGAARD SD, Schmidt M, Horvath-Puho E, Thomsen RW, et al
    Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence?
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00762.
    >> Share

  702. SANDERS RW, de Jong MD
    Pandemic moves and countermoves: vaccines and viral variants.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00730.
    >> Share

  703. MYLAN S, Hardman C
    COVID-19, cults, and the anti-vax movement.
    Lancet. 2021;397:1181.
    >> Share

  704. USHER AD
    Uncertainties over EU COVID-19 vaccine sharing scheme.
    Lancet. 2021;397:1171.
    >> Share

  705. THE LANCET
    COVID-19: building a stronger Europe.
    Lancet. 2021;397:1157.
    >> Share

  706. HIPGRAVE DB, Kampo A, Pearson L
    Health systems in the ACT-A.
    Lancet. 2021;397:1181-1182.
    >> Share

  707. KLUGE H, McKee M
    COVID-19 vaccines for the European region: an unprecedented challenge.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00709.
    >> Share

  708. NABETH P, Hassan M, Adib K, Abubakar A, et al
    New COVID-19 resurgence in the WHO Eastern Mediterranean region.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00679.
    >> Share


  709. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2021 Mar 24. pii: S0140-6736(21)00708.
    >> Share

  710. KRISTIANSEN PA, Page M, Bernasconi V, Mattiuzzo G, et al
    WHO International Standard for anti-SARS-CoV-2 immunoglobulin.
    Lancet. 2021 Mar 23. pii: S0140-6736(21)00527.
    >> Share

  711. MUNDT AP
    Assessing government responsibility for COVID-19 deaths.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00529.
    >> Share

  712. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    Guidelines should not pool evidence from uncomplicated and severe COVID-19.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00469.
    >> Share

  713. KARIM SSA
    Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00468.
    >> Share

  714. CHAKRABORTY D, Agrawal A, Maiti S
    Rapid identification and tracking of SARS-CoV-2 variants of concern.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00470.
    >> Share

  715. NKEREUWEM E, Kampmann B, Togun T
    The need to prioritise childhood tuberculosis case detection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
    >> Share

  716. HE Z, Ren L, Yang J, Guo L, et al
    Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    Lancet. 2021;397:1075-1084.
    >> Share

  717. JAFFE S
    Biden's first legislative victory: $1.9 trillion for COVID-19.
    Lancet. 2021;397:1047-1048.
    >> Share

  718. STRUGNELL R, Wang N
    Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.
    Lancet. 2021;397:1037-1039.
    >> Share

  719. GILL PS, Poduval S, Thakur JS, Iqbal R, et al
    COVID-19, community trials, and inclusion.
    Lancet. 2021;397:1036-1037.
    >> Share

  720. CRISP N
    Human flourishing in a health-creating society.
    Lancet. 2021;397:1054-1055.
    >> Share

  721. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    >> Share

  722. BOZORGMEHR K, Jahn R, Stuckler D, McKee M, et al
    Free licensing of vaccines to end the COVID-19 crisis.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00467.
    >> Share

  723. HANSEN CH, Michlmayr D, Gubbels SM, Molbak K, et al
    Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00575.
    >> Share

  724. TURNER P, Montgomery H, Stroud M, Grimble G, et al
    Malnutrition risk in hospitalised COVID-19 patients receiving CPAP.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00447.
    >> Share

  725. BOYTON RJ, Altmann DM
    Risk of SARS-CoV-2 reinfection after natural infection.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00662.
    >> Share

  726. KRIEGER N, Waterman PD, Chen JT, Testa C, et al
    Missing again: US racial and ethnic data for COVID-19 vaccination.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00465.
    >> Share

  727. SHAKESPEARE T, Ndagire F, Seketi QE
    Triple jeopardy: disabled people and the COVID-19 pandemic.
    Lancet. 2021 Mar 16. pii: S0140-6736(21)00625.
    >> Share

  728. HOLT E
    Countries split from EU on COVID-19 vaccines.
    Lancet. 2021;397:958.
    >> Share

  729. THE LANCET
    Access to COVID-19 vaccines: looking beyond COVAX.
    Lancet. 2021;397:941.
    >> Share

  730. AUCOTT JN, Rebman AW
    Long-haul COVID: heed the lessons from other infection-triggered illnesses.
    Lancet. 2021;397:967-968.
    >> Share

  731. COUSINS S
    Australian Commission calls for overhaul of aged care.
    Lancet. 2021;397:957.
    >> Share

  732. DEVI S
    Health in Syria: a decade of conflict.
    Lancet. 2021;397:955-956.
    >> Share

  733. WILLIAMS R, Alessi C, Alexander G, Allison M, et al
    New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK.
    Lancet. 2021 Mar 10. pii: S0140-6736(20)32396.
    >> Share

  734. GURDASANI D, Alwan NA, Greenhalgh T, Hyde Z, et al
    School reopening without robust COVID-19 mitigation risks accelerating the pandemic.
    Lancet. 2021 Mar 10. pii: S0140-6736(21)00622.
    >> Share

  735. LURIE N, Keusch GT, Dzau VJ
    Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development.
    Lancet. 2021 Mar 9. pii: S0140-6736(21)00503.
    >> Share

  736. STEINBERG J, Thomas A, Iravani A
    (18)Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
    Lancet. 2021 Mar 8. pii: S0140-6736(21)00464.
    >> Share

  737. USHER AD
    Medical oxygen crisis: a belated COVID-19 response.
    Lancet. 2021;397:868-869.
    >> Share

  738. HUNG IFN, Poland GA
    Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.
    Lancet. 2021;397:854-855.
    >> Share

  739. SAMARASEKERA U
    Robin Shattock: novel vaccine developer.
    Lancet. 2021;397:870.
    >> Share

  740. SROUR SA
    Social action to achieve a dignified life for people with disabilities in the occupied Palestinian territory.
    Lancet. 2021;397:861-862.
    >> Share

  741. SOE ZW, Oo MM, Wah KS, Naing AT, et al
    Myanmar's health leaders stand against military rule.
    Lancet. 2021;397:875.
    >> Share

  742. HEIDKAMP RA, Piwoz E, Gillespie S, Keats EC, et al
    Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the Sustainable Development Goals: an agenda for action.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00568.
    >> Share

  743. VICTORA CG, Christian P, Vidaletti LP, Gatica-Dominguez G, et al
    Revisiting maternal and child undernutrition in low-income and middle-income countries: variable progress towards an unfinished agenda.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00394.
    >> Share

  744. MADAD S, Spencer C
    The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00433.
    >> Share

  745. VIJAYASINGHAM L, Bischof E, Wolfe J
    Sex-disaggregated data in COVID-19 vaccine trials.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00384.
    >> Share


  746. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Mar 4. pii: S0140-6736(21)00461.
    >> Share

    February 2021
  747. BATNIJI R
    Historical evidence to inform COVID-19 vaccine mandates.
    Lancet. 2021;397:791.
    >> Share

  748. CHAUVIN L
    Peruvian COVID-19 vaccine scandal spreads.
    Lancet. 2021;397:783.
    >> Share

  749. ZAROCOSTAS J
    New WTO leader faces COVID-19 challenges.
    Lancet. 2021;397:782.
    >> Share

  750. PEYRE M, Vourc'h G, Lefrancois T, Martin-Prevel Y, et al
    PREZODE: preventing zoonotic disease emergence.
    Lancet. 2021;397:792-793.
    >> Share

  751. SHAHRIZAILA N, Lehmann HC, Kuwabara S
    Guillain-Barre syndrome.
    Lancet. 2021 Feb 26. pii: S0140-6736(21)00517.
    >> Share

  752. MANISTY C, Otter AD, Treibel TA, McKnight A, et al
    Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00501.
    >> Share

  753. PRENDECKI M, Clarke C, Brown J, Cox A, et al
    Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00502.
    >> Share

  754. WHITAKER DK
    UK COVID-19 public inquiry and lessons from patient safety.
    Lancet. 2021 Feb 24. pii: S0140-6736(21)00381.
    >> Share

  755. GODDARD AF, Patel M
    The changing face of medical professionalism and the impact of COVID-19.
    Lancet. 2021 Feb 23. pii: S0140-6736(21)00436.
    >> Share

  756. SIVA N
    Severe mental illness: reassessing COVID-19 vaccine priorities.
    Lancet. 2021;397:657.
    >> Share

  757. HYDE R
    von der Leyen admits to COVID-19 vaccine failures.
    Lancet. 2021;397:655-656.
    >> Share

  758. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    >> Share

  759. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    >> Share

  760. THE LANCET
    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    >> Share

  761. VOYSEY M, Costa Clemens SA, Madhi SA, Weckx LY, et al
    Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00432.
    >> Share

  762. SISA I, Noblecilla E, Orozco F
    Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00357.
    >> Share

  763. BERK J, Brinkley-Rubinstein L, Murphy M, Chan P, et al
    MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00354.
    >> Share

  764. ROBERTSON JFR, Sewell HF, Stewart M
    Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00455.
    >> Share

  765. FIELDS EL, Copeland R, Hopkins E
    Same script, different viruses: HIV and COVID-19 in US Black communities.
    Lancet. 2021 Feb 18. pii: S0140-6736(20)32522.
    >> Share

  766. BEYRER C, Adimora AA, Hodder SL, Hopkins E, et al
    Call to action: how can the US Ending the HIV Epidemic initiative succeed?
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00390.
    >> Share

  767. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00448.
    >> Share

  768. KATES J, Dawson L, Horn TH, Killelea A, et al
    Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
    >> Share

  769. MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
    The persistent and evolving HIV epidemic in American men who have sex with men.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
    >> Share

  770. MINA MJ, Peto TE, Garcia-Finana M, Semple MG, et al
    Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
    Lancet. 2021 Feb 17. pii: S0140-6736(21)00425.
    >> Share

  771. SKEGG D, Gluckman P, Boulton G, Hackmann H, et al
    Future scenarios for the COVID-19 pandemic.
    Lancet. 2021 Feb 16. pii: S0140-6736(21)00424.
    >> Share

  772. DALL'ALBA R, Rocha CF, de Pinho Silveira R, da Silva Costa Dresch L, et al
    COVID-19 in Brazil: far beyond biopolitics.
    Lancet. 2021;397:579-580.
    >> Share

  773. MAKONI M
    Tanzania refuses COVID-19 vaccines.
    Lancet. 2021;397:566.
    >> Share

  774. BERWANGER O
    Azithromycin, RECOVERY, and the power of large, simple trials.
    Lancet. 2021;397:559-560.
    >> Share

  775. SIVA N
    New global initiative to tackle Alzheimer's disease.
    Lancet. 2021;397:568-569.
    >> Share

  776. SINGH NS, Lokot M, Undie CC, Onyango MA, et al
    Research in forced displacement: guidance for a feminist and decolonial approach.
    Lancet. 2021;397:560-562.
    >> Share

  777. THE LANCET
    Improving prisoner health for stronger public health.
    Lancet. 2021;397:555.
    >> Share


  778. Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00388.
    >> Share

  779. WOUTERS OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, et al
    Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00306.
    >> Share

  780. FONTANET A, Autran B, Lina B, Kieny MP, et al
    SARS-CoV-2 variants and ending the COVID-19 pandemic.
    Lancet. 2021 Feb 11. pii: S0140-6736(21)00370.
    >> Share

  781. MARTIN S, Arawi T
    Ensure Palestinians have access to COVID-19 vaccines.
    Lancet. 2021 Feb 9. pii: S0140-6736(21)00190.
    >> Share

  782. BURKI T
    Understanding variants of SARS-CoV-2.
    Lancet. 2021;397:462.
    >> Share

  783. ZAROCOSTAS J
    WHO team begins COVID-19 origin investigation.
    Lancet. 2021;397:459.
    >> Share

  784. HORTON R
    Offline: COVID-19 and the convergence of nations.
    Lancet. 2021;397:458.
    >> Share

  785. GORNA R, MacDermott N, Rayner C, O'Hara M, et al
    Long COVID guidelines need to reflect lived experience.
    Lancet. 2021;397:455-457.
    >> Share

  786. BEHRENS RH, Patel V
    Avoiding shoulder injury from intramuscular vaccines.
    Lancet. 2021;397:471.
    >> Share

  787. WARRELL MJ
    Time to revise the strategy for Gavi funding of rabies vaccine?
    Lancet. 2021;397:471-472.
    >> Share

  788. LANE R
    Tahmeed Ahmed: new leader of icddr,b.
    Lancet. 2021;397:463.
    >> Share

  789. THE LANCET
    Genomic sequencing in pandemics.
    Lancet. 2021;397:445.
    >> Share

  790. CLARFIELD AM, Skorecki K, Manor O, Glick S, et al
    A COVID-19 jab in the right direction.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00310.
    >> Share

  791. KAMPF G, Kulldorff M
    Calling for benefit-risk evaluations of COVID-19 control measures.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00193.
    >> Share

  792. LOIZIDES U, Adisa A, de la Rica Manjavacas AL, Robertson JS, et al
    WHO international non-proprietary names: the need to distinguish COVID-19 vaccines.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00099.
    >> Share

  793. MEREWOOD A, Bode L, Davanzo R, Perez-Escamilla R, et al
    Breastfeed or be vaccinated-an unreasonable default recommendation.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00197.
    >> Share

  794. JONES I, Roy P
    Sputnik V COVID-19 vaccine candidate appears safe and effective.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00191.
    >> Share


  795. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00149.
    >> Share

  796. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, et al
    Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00234.
    >> Share

  797. FRIESEN P, Caplan AL, Miller JE
    COVID-19 vaccine research and the trouble with clinical equipoise.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00198.
    >> Share

  798. TUYISENGE G, Goldenberg SM
    COVID-19, structural racism, and migrant health in Canada.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00215.
    >> Share

    January 2021
  799. MUGUNGA JC, Tyagi K, Bernal-Serrano D, Correa N, et al
    SARS-CoV-2 serosurveys in low-income and middle-income countries.
    Lancet. 2021;397:353-355.
    >> Share

  800. SAMARASEKERA U
    Fransisca Handy Agung: improving adolescent health in Indonesia.
    Lancet. 2021;397:365.
    >> Share

  801. DANIELS JP
    Health experts slam Bolsonaro's vaccine comments.
    Lancet. 2021;397:361.
    >> Share

  802. THE LANCET
    Health and care workers are owed a better future.
    Lancet. 2021;397:347.
    >> Share

  803. HALLAL PC
    SOS Brazil: science under attack.
    Lancet. 2021;397:373-374.
    >> Share

  804. BLAKNEY AK, McKay PF
    Next-generation COVID-19 vaccines: here come the proteins.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00258.
    >> Share

  805. RICHMOND P, Hatchuel L, Dong M, Ma B, et al
    Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00241.
    >> Share


  806. Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00242.
    >> Share

  807. WATT G, Giacaman R, Zurayk H, Bjertness E, et al
    COVID-19 vaccines for Palestinians.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00185.
    >> Share

  808. SABINO EC, Buss LF, Carvalho MPS, Prete CA Jr, et al
    Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
    Lancet. 2021 Jan 27. pii: S0140-6736(21)00183.
    >> Share

  809. BARDAJI A, Sevene E, Cutland C, Menendez C, et al
    The need for a global COVID-19 maternal immunisation research plan.
    Lancet. 2021 Jan 25. pii: S0140-6736(21)00146.
    >> Share

  810. VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
    Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
    Lancet. 2021;397:277-278.
    >> Share

  811. NASRALLAH MP, Mourelatos Z, Lee EB
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:277.
    >> Share

  812. GLATZEL M, Hagel C, Matschke J, Sperhake J, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276.
    >> Share

  813. EGERVARI K, Thomas C, Lobrinus JA, Kuhlmann T, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276-277.
    >> Share

  814. AGIUS RM, Kendrick D, Sewell HF, Stewart M, et al
    Reaffirming health and safety precautionary principles for COVID-19 in the UK.
    Lancet. 2021;397:274.
    >> Share

  815. MAKONI M
    South Africa responds to new SARS-CoV-2 variant.
    Lancet. 2021;397:267.
    >> Share

  816. BHUYAN A
    India begins COVID-19 vaccination amid trial allegations.
    Lancet. 2021;397:264.
    >> Share

  817. THE LANCET
    COVID-19: the intersection of education and health.
    Lancet. 2021;397:253.
    >> Share

  818. MARCHALIK D, Lipsky A
    Transformative experiences and A Young Doctor's Notebook.
    Lancet. 2021;397:270.
    >> Share

  819. USHER AD
    CEPI criticised for lack of transparency.
    Lancet. 2021;397:265-266.
    >> Share

  820. JAFFE S
    Rochelle Walensky: new Director of the US CDC.
    Lancet. 2021;397:268.
    >> Share

  821. LAU E, Wang HH, Qiao J, Jiang B, et al
    Wakley-Wu Lien Teh Prize Essay 2020: passing the baton to the next generation of health workers.
    Lancet. 2021;397:261-262.
    >> Share

  822. WISE PH, Shiel A, Southard N, Bendavid E, et al
    The political and security dimensions of the humanitarian health response to violent conflict.
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00130.
    >> Share

  823. PATEL MS, Phillips CB
    COVID-19 and the moral imagination.
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00151.
    >> Share

  824. PRIESEMANN V, Balling R, Brinkmann MM, Ciesek S, et al
    An action plan for pan-European defence against new SARS-CoV-2 variants.
    Lancet. 2021 Jan 21. pii: S0140-6736(21)00150.
    >> Share

  825. IMPOUMA B, Mboussou F, Kasolo F, Yoti Z, et al
    Preparing for a COVID-19 resurgence in the WHO African region.
    Lancet. 2021 Jan 20. pii: S0140-6736(20)32725.
    >> Share

  826. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Lancet. 2021;397:197-198.
    >> Share

  827. DOLHNIKOFF M, Duarte-Neto AN, Saldiva PHN, Caldini EG, et al
    Using EM data to understand COVID-19 pathophysiology.
    Lancet. 2021;397:196-197.
    >> Share

  828. WEBSTER P
    COVID-19 highlights Canada's care home crisis.
    Lancet. 2021;397:183.
    >> Share

  829. LANE R
    Anne Johnson: Dame of public health epidemiology.
    Lancet. 2021;397:186.
    >> Share

  830. JAFFE S
    New leadership at the US CDC.
    Lancet. 2021;397:182.
    >> Share

  831. THE LANCET
    An opportunity for American renewal.
    Lancet. 2021;397:171.
    >> Share

  832. CAVALERI M, Enzmann H, Straus S, Cooke E, et al
    The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines.
    Lancet. 2021 Jan 13. pii: S0140-6736(21)00085.
    >> Share

  833. BARBARO RP, MacLaren G, Brodie D
    ECMO support for COVID-19: a balancing act - Authors' reply.
    Lancet. 2021;397:95.
    >> Share

  834. ZHANG Y, Ji B, Zhou Z
    ECMO support for COVID-19: a balancing act.
    Lancet. 2021;397:94-95.
    >> Share

  835. KUSIN S, Choo E
    Parenting in the time of COVID-19.
    Lancet. 2021;397:86.
    >> Share

  836. USHER AD
    Health systems neglected by COVID-19 donors.
    Lancet. 2021;397:83.
    >> Share

  837. KNEEBONE R, Schlegel C
    Thinking across disciplinary boundaries in a time of crisis.
    Lancet. 2021;397:89-90.
    >> Share

  838. COUSINS S
    Polio in Afghanistan: a changing landscape.
    Lancet. 2021;397:84-85.
    >> Share

  839. WATTS N, Amann M, Arnell N, Ayeb-Karlsson S, et al
    The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises.
    Lancet. 2021;397:129-170.
    >> Share

  840. CORTINOVIS M, Perico N, Remuzzi G
    Long-term follow-up of recovered patients with COVID-19.
    Lancet. 2021 Jan 8. pii: S0140-6736(21)00039.
    >> Share

  841. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2021 Jan 8. pii: S0140-6736(20)32656.
    >> Share

  842. THE LANCET
    Health as a foundation for society.
    Lancet. 2021;397:1.
    >> Share

  843. DEVI S
    2021: a year of humanitarian need.
    Lancet. 2021;397:12-13.
    >> Share

  844. GOSTIN LO, Shalala DE, Hamburg MA, Bloom BR, et al
    A global health action agenda for the Biden administration.
    Lancet. 2021;397:5-8.
    >> Share

  845. KNIPPER M, Bozorgmehr K, Offe J, Orcutt M, et al
    Germany's new global health strategy: leaving migrants behind.
    Lancet. 2021;397:20-21.
    >> Share

  846. ROBERTS DE
    Abolish race correction.
    Lancet. 2021;397:17-18.
    >> Share

  847. ROCHON PA, Stall NM, Gurwitz JH
    Making older women visible.
    Lancet. 2021;397:21.
    >> Share

    December 2020
  848. CLAESON M, Hanson S
    COVID-19 and the Swedish enigma.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32750.
    >> Share

  849. HARMAN S, Herten-Crabb A, Morgan R, Smith J, et al
    COVID-19 vaccines and women's security.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32727.
    >> Share

  850. GOODMAN J, de Prudhoe K, Williams C
    UK COVID-19 public inquiry needed to learn lessons and save lives.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32726.
    >> Share

  851. SAYAMPANATHAN AA, Heng CS, Pin PH, Pang J, et al
    Infectivity of asymptomatic versus symptomatic COVID-19.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32651.
    >> Share

  852. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32625.
    >> Share

  853. WOODHAMS C, Dacre J, Parnerkar I, Sharma M, et al
    Pay gaps in medicine and the impact of COVID-19 on doctors' careers.
    Lancet. 2020 Dec 15. pii: S0140-6736(20)32671.
    >> Share

  854. KUNG S, Doppen M, Black M, Hills T, et al
    Reduced mortality in New Zealand during the COVID-19 pandemic.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32647.
    >> Share

  855. FITZPATRICK MC, Pandey A, Wells CR, Sah P, et al
    Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32635.
    >> Share

  856. BRAUN F, Edler C, Puelles VG, Huber TB, et al
    Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.
    Lancet. 2020;396:1881-1882.
    >> Share

  857. CHOY KW
    Association of SARS-CoV-2 renal tropism with acute kidney injury.
    Lancet. 2020;396:1880-1881.
    >> Share

  858. LANGE B
    Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic.
    Lancet. 2020;396:1880.
    >> Share

  859. TOPOL EJ
    Is my cough COVID-19?
    Lancet. 2020;396:1874.
    >> Share

  860. SIVA N
    Experts call to include prisons in COVID-19 vaccine plans.
    Lancet. 2020;396:1870.
    >> Share

  861. THE LANCET
    Facing up to long COVID.
    Lancet. 2020;396:1861.
    >> Share

  862. BURGESS RA, Osborne RH, Yongabi KA, Greenhalgh T, et al
    The COVID-19 vaccines rush: participatory community engagement matters more than ever.
    Lancet. 2020 Dec 10. pii: S0140-6736(20)32642.
    >> Share

  863. ARYEETEY E, Engebretsen E, Gornitzka A, Maassen P, et al
    A step backwards in the fight against global vaccine inequities.
    Lancet. 2020 Dec 9. pii: S0140-6736(20)32596.
    >> Share

  864. KNOLL MD, Wonodi C
    Oxford-AstraZeneca COVID-19 vaccine efficacy.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32623.
    >> Share

  865. VOYSEY M, Clemens SAC, Madhi SA, Weckx LY, et al
    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32661.
    >> Share

  866. USHER AD
    South Africa and India push for COVID-19 patents ban.
    Lancet. 2020;396:1790-1791.
    >> Share

  867. HORTON R
    Offline: COVID-19-what have we learned so far?
    Lancet. 2020;396:1789.
    >> Share

  868. THE LANCET
    An African plan to control COVID-19 is urgently needed.
    Lancet. 2020;396:1777.
    >> Share

  869. MOLYNEUX DH, Eberhard ML, Cleaveland S, Addey R, et al
    Certifying Guinea worm eradication: current challenges.
    Lancet. 2020;396:1857-1860.
    >> Share

  870. BRIGGS ADM, Fraser C
    Is NHS Test and Trace exacerbating COVID-19 inequalities?
    Lancet. 2020 Dec 4. pii: S0140-6736(20)32593.
    >> Share

  871. THE LANCET
    Climate and COVID-19: converging crises.
    Lancet. 2020 Dec 2. pii: S0140-6736(20)32579.
    >> Share

  872. LAL A, Erondu NA, Heymann DL, Gitahi G, et al
    Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.
    Lancet. 2020 Dec 1. pii: S0140-6736(20)32228.
    >> Share

    November 2020
  873. HERNANDEZ JM
    SARS-CoV-2 risk misclassification explains poor COVID-19 management.
    Lancet. 2020;396:1733-1734.
    >> Share

  874. MENDENHALL E
    The COVID-19 syndemic is not global: context matters.
    Lancet. 2020;396:1731.
    >> Share

  875. FODJE T, Choo E
    Applying for residency in the time of COVID-19.
    Lancet. 2020;396:1718.
    >> Share

  876. COUSINS S
    Afghanistan braced for second wave of COVID-19.
    Lancet. 2020;396:1716-1717.
    >> Share

  877. HORTON R
    Offline: Europe and COVID-19-struggling with tragedy.
    Lancet. 2020;396:1713.
    >> Share

  878. THE LANCET
    Maintaining the HIV response in a world shaped by COVID-19.
    Lancet. 2020;396:1703.
    >> Share

  879. GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
    Centring adolescent girls and young women in the HIV and COVID-19 responses.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.
    >> Share

  880. BEYRER C, Sullivan P, Adimora AA, Mayer K, et al
    HIV in the USA: priorities for the new administration.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32524.
    >> Share

  881. HILLS T, Kearns N, Kearns C, Beasley R, et al
    Influenza control during the COVID-19 pandemic.
    Lancet. 2020;396:1633-1634.
    >> Share

  882. THE LANCET
    COVID-19 vaccines: no time for complacency.
    Lancet. 2020;396:1607.
    >> Share

  883. GRIFFITHS C, Mitchell M, Burnand A
    More support needed for UK charity-funded medical research.
    Lancet. 2020;396:1616-1618.
    >> Share

  884. AL-MANDHARI AS, Brennan RJ, Abubakar A, Hajjeh R, et al
    Tackling COVID-19 in the Eastern Mediterranean Region.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32349.
    >> Share

  885. MATHUR R, Bear L, Khunti K, Eggo RM, et al
    Urgent actions and policies needed to address COVID-19 among UK ethnic minorities.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32465.
    >> Share

  886. RAMASAMY MN, Minassian AM, Ewer KJ, Flaxman AL, et al
    Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
    Lancet. 2020 Nov 18. pii: S0140-6736(20)32466.
    >> Share

  887. ANDREW MK, McElhaney JE
    Age and frailty in COVID-19 vaccine development.
    Lancet. 2020 Nov 18. pii: S0140-6736(20)32481.
    >> Share

  888. STEFANICK ML, Schiebinger L
    Analysing how sex and gender interact.
    Lancet. 2020;396:1553-1554.
    >> Share

  889. CHANDAN JS
    Improving global surveillance of gender-based violence.
    Lancet. 2020;396:1562.
    >> Share

  890. AL KNAWY B, Adil M, Crooks G, Rhee K, et al
    The Riyadh Declaration: the role of digital health in fighting pandemics.
    Lancet. 2020;396:1537-1539.
    >> Share

  891. SHAW A, Flott K, Fontana G, Durkin M, et al
    No patient safety without health worker safety.
    Lancet. 2020;396:1541-1543.
    >> Share

  892. MOLLICA RF, Fernando D
    When racial trauma is a chief complaint among health-care staff.
    Lancet. 2020;396:e84.
    >> Share

  893. CASTRO A
    Maternal and child mortality worsens in Latin America and the Caribbean.
    Lancet. 2020;396:e85.
    >> Share

  894. PONIKOWSKI P, Kirwan BA, Anker SD, McDonagh T, et al
    Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32339.
    >> Share

  895. FORE HH, Ghebreyesus TA, Watkins K, Greenslade L, et al
    Leveraging the COVID-19 response to end preventable child deaths from pneumonia.
    Lancet. 2020 Nov 11. pii: S0140-6736(20)32348.
    >> Share

  896. ZIMERMAN A, Lopes RD, D'Avila A, Rohde LE, et al
    COVID-19 in Brazil: the headlines should be about science.
    Lancet. 2020 Nov 10. pii: S0140-6736(20)32375.
    >> Share

  897. GURDASANI D, Bear L, Bogaert D, Burgess RA, et al
    The UK needs a sustainable strategy for COVID-19.
    Lancet. 2020 Nov 9. pii: S0140-6736(20)32350.
    >> Share

  898. KRIEGER N, Testa C, Hanage WP, Chen JT, et al
    US racial and ethnic data for COVID-19 cases: still missing in action.
    Lancet. 2020;396:e81.
    >> Share

  899. COVIDSURG COLLABORATIVE
    Surgery during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:e79.
    >> Share

  900. VUTHALURU S, Koliyadan SV, Kanniwadi SS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e78.
    >> Share

  901. MEECHAM L, Shakarchi JA, Rahman HP, Nyamekye IK, et al
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e77.
    >> Share

  902. ALDERMAN J
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e76.
    >> Share

  903. RODRIGUES J, Chan JK, Issa F
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e75.
    >> Share

  904. SHANTHANNA H, Uppal V
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e74.
    >> Share

  905. HAMID HKS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e73.
    >> Share

  906. HUNG IF, Yuen KY
    Early triple antiviral therapy for COVID-19 - Authors' reply.
    Lancet. 2020;396:1488.
    >> Share

  907. LEE N, Ison M, Dunning J
    Early triple antiviral therapy for COVID-19.
    Lancet. 2020;396:1487-1488.
    >> Share

  908. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Lancet. 2020;396:1486-1487.
    >> Share

  909. LODGE A
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1486.
    >> Share

  910. CHAUHAN A, Agarwal A, Jaiswal N, Singh M, et al
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1485-1486.
    >> Share

  911. HOFFMANN C, Wolf E
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    >> Share

  912. POLLAN M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, et al
    SARS-CoV-2 seroprevalence in Spain - Authors' reply.
    Lancet. 2020;396:1484-1485.
    >> Share

  913. GEORGE TP
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    >> Share

  914. HORTON R
    Offline: Managing the COVID-19 vaccine infodemic.
    Lancet. 2020;396:1474.
    >> Share

  915. DZAU VJ, Balatbat C
    Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations.
    Lancet. 2020;396:1469-1471.
    >> Share

  916. THE LANCET
    COVID-19 in Latin America: a humanitarian crisis.
    Lancet. 2020;396:1463.
    >> Share

  917. BHADORIA AS, Gawande K, Sharma R, Mohapatra A, et al
    Institutional versus home isolation to curb the COVID-19 outbreak.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32161.
    >> Share

  918. WILDER-SMITH A, Cook AR, Dickens BL
    Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32171.
    >> Share

  919. SMITH MJ, Ujewe S, Katz R, Upshur REG, et al
    Emergency use authorisation for COVID-19 vaccines: lessons from Ebola.
    Lancet. 2020 Nov 5. pii: S0140-6736(20)32337.
    >> Share

  920. ANDERSON RM, Vegvari C, Truscott J, Collyer BS, et al
    Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
    Lancet. 2020 Nov 4. pii: S0140-6736(20)32318.
    >> Share

  921. HOPKINS C, Smith B
    Widespread smell testing for COVID-19 has limited application.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32317.
    >> Share

  922. MENNI C, Sudre CH, Steves CJ, Ourselin S, et al
    Widespread smell testing for COVID-19 has limited application - Authors' reply.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32316.
    >> Share

    October 2020
  923. OKELL LC, Verity R, Katzourakis A, Volz EM, et al
    Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
    Lancet. 2020;396:1397.
    >> Share

  924. GORTAZAR C, Del-Rio FJR, Dominguez L, de la Fuente J, et al
    Host or pathogen-related factors in COVID-19 severity?
    Lancet. 2020;396:1396-1397.
    >> Share

  925. QU Z, Oedingen C, Bartling T, Schrem H, et al
    Organ procurement and transplantation in Germany during the COVID-19 pandemic.
    Lancet. 2020;396:1395.
    >> Share

  926. REDDY S, Dumbill R, Akhtar MZ, Udupa V, et al
    Transplant programmes in areas with high SARS-CoV-2 transmission.
    Lancet. 2020;396:1395-1396.
    >> Share

  927. TREIBEL TA, Manisty C, Andiapen M, Pade C, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1394-1395.
    >> Share

  928. CHOW A, Htun HL, Kyaw WM, Lee LT, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393-1394.
    >> Share

  929. FENNELLY K, Whalen CC
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393.
    >> Share

  930. HOLT E
    Slovakia to test all adults for SARS-CoV-2.
    Lancet. 2020;396:1386-1387.
    >> Share

  931. HORTON R
    Offline: COVID-19-a crisis of power.
    Lancet. 2020;396:1383.
    >> Share

  932. FREUDENTHAL R, Horowitz M, Jadhav S, Moncrieff J, et al
    Lack of safeguards in response to restrictive public health measures.
    Lancet. 2020;396:e70.
    >> Share

  933. HASSAN-SMITH Z, Hanif W, Khunti K
    Who should be prioritised for COVID-19 vaccines?
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32224.
    >> Share

  934. KENYON C
    Syndemic responses to COVID-19 should include an ecological dimension.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32219.
    >> Share

  935. KRAUSE PR, Fleming TR, Ellenberg SS, Henao-Restrepo AM, et al
    Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32259.
    >> Share

  936. BINGHAM K
    The UK Government's Vaccine Taskforce: strategy for protecting the UK and the world.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32175.
    >> Share

  937. FERIGATO S, Fernandez M, Amorim M, Ambrogi I, et al
    The Brazilian Government's mistakes in responding to the COVID-19 pandemic.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32164.
    >> Share

  938. STEWART R, El-Harakeh A, Cherian SA
    Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32141.
    >> Share

  939. PAES-SOUSA R, Millett C, Rocha R, Barreto ML, et al
    Science misuse and polarised political narratives in the COVID-19 response.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32168.
    >> Share

  940. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    Use of adenovirus type-5 vectored vaccines: a cautionary tale.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32156.
    >> Share

  941. THE LANCET
    Global health: time for radical change?
    Lancet. 2020;396:1129.
    >> Share

  942. PETO J, Hunter DJ, Riboli E, Griffin JL, et al
    Unnecessary obstacles to COVID-19 mass testing.
    Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.
    >> Share

  943. USUELLI M
    The Lombardy region of Italy launches the first investigative COVID-19 commission.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32154.
    >> Share

  944. ALWAN NA, Burgess RA, Ashworth S, Beale R, et al
    Scientific consensus on the COVID-19 pandemic: we need to act now.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32153.
    >> Share

  945. POLAND GA, Ovsyannikova IG, Kennedy RB
    SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32137.
    >> Share

  946. HONIGSBAUM M, Krishnan L
    Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
    Lancet. 2020 Oct 12. pii: S0140-6736(20)32134.
    >> Share

  947. BLUKACZ A, Cabieses B
    COVID-19: leaving no one behind in Latin America.
    Lancet. 2020;396:1070.
    >> Share

  948. CHARLIER P, Varison L
    Is COVID-19 being used as a weapon against Indigenous Peoples in Brazil?
    Lancet. 2020;396:1069-1070.
    >> Share

  949. KUDERER NM, Wulff-Burchfield E, Rubinstein SM, Grivas P, et al
    Cancer and COVID-19 - Authors' reply.
    Lancet. 2020;396:1067-1068.
    >> Share

  950. MALEK AE, Raad II, Jabbour E
    Cancer and COVID-19.
    Lancet. 2020;396:1066-1067.
    >> Share

  951. MORIS D, Tsilimigras DI, Schizas D
    Cancer and COVID-19.
    Lancet. 2020;396:1066.
    >> Share

  952. GROSS R, Conzelmann C, Muller JA, Reister F, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1065-1066.
    >> Share

  953. CUMMINGS MJ, O'Donnell MR
    Study of critically ill patients with COVID-19 in New York City - Authors' reply.
    Lancet. 2020;396:1064.
    >> Share

  954. SHENKER NS, Wesolowska A, van Goudoever JB, Nangia S, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic.
    Lancet. 2020;396:1064-1065.
    >> Share

  955. PIOVANI D, Bonovas S
    Study of critically ill patients with COVID-19 in New York City.
    Lancet. 2020;396:1064.
    >> Share

  956. CALLENDER B, Obuobi S, Czerwiec MK, Williams I, et al
    COVID-19, comics, and the visual culture of contagion.
    Lancet. 2020;396:1061-1063.
    >> Share

  957. COUSINS S
    2.5 million more child marriages due to COVID-19 pandemic.
    Lancet. 2020;396:1059.
    >> Share

  958. THE LANCET
    Mental health: time to invest in quality.
    Lancet. 2020;396:1045.
    >> Share

  959. FRUMKIN H, Myers SS
    Planetary health and the 2020 US election.
    Lancet. 2020;396:1048-1050.
    >> Share

  960. ALLOTEY P, Denton F
    Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on.
    Lancet. 2020;396:1053-1055.
    >> Share

  961. CARLET J, Payen D, Opal SM
    Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
    Lancet. 2020 Oct 9. pii: S0140-6736(20)32132.
    >> Share

  962. VAN TULLEKEN C, Wright C, Brown A, McCoy D, et al
    Marketing of breastmilk substitutes during the COVID-19 pandemic.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32119.
    >> Share

  963. BEDFORD J, Enria D, Giesecke J, Heymann DL, et al
    Living with the COVID-19 pandemic: act now with the tools we have.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32117.
    >> Share


  964. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32013.
    >> Share

  965. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32079.
    >> Share

  966. BOZORGMEHR K
    Power of and power over COVID-19 response guidelines.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32081.
    >> Share

  967. CAO B, Hayden FG
    Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32078.
    >> Share

  968. DENING KH, Lloyd-Williams M
    Minimising long-term effect of COVID-19 in dementia care.
    Lancet. 2020;396:957-958.
    >> Share

  969. WANG Y, Gu X, Xu J, Cao B, et al
    Remdesivir and COVID-19 - Authors' reply.
    Lancet. 2020;396:954.
    >> Share

  970. WANG LY, Cui JJ, Ouyang QY, Zhan Y, et al
    Remdesivir and COVID-19.
    Lancet. 2020;396:953-954.
    >> Share

  971. EDWARDS JK, Cole SR, Adimora AA
    Remdesivir and COVID-19.
    Lancet. 2020;396:953.
    >> Share

  972. GLAUS MJ, Von Ruden S
    Remdesivir and COVID-19.
    Lancet. 2020;396:952.
    >> Share

  973. DENNIS A
    Remdesivir and COVID-19.
    Lancet. 2020;396:952.
    >> Share

  974. MCMAHON JH, Hoy JF, Kamarulzaman A, Bekker LG, et al
    Leveraging the advances in HIV for COVID-19.
    Lancet. 2020;396:943-944.
    >> Share

  975. THE LANCET
    Building a resilient NHS, for COVID-19 and beyond.
    Lancet. 2020;396:935.
    >> Share

    September 2020
  976. CAUCHEMEZ S, Kiem CT, Paireau J, Rolland P, et al
    Lockdown impact on COVID-19 epidemics in regions across metropolitan France.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32034.
    >> Share

  977. STRATHDEE SA, Davies SC, Marcelin JR
    Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32063.
    >> Share

  978. LASRY A, Horth R
    Models for mortality require tailoring in the context of the COVID-19 pandemic.
    Lancet. 2020;396:883.
    >> Share

  979. BANERJEE A, Pasea L, Denaxas S, Williams B, et al
    Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:883-884.
    >> Share

  980. HAGAY Z
    Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic.
    Lancet. 2020;396:882.
    >> Share

  981. HORTON R
    Offline: COVID-19 is not a pandemic.
    Lancet. 2020;396:874.
    >> Share

  982. THE LANCET
    COVID-19 in India: the dangers of false optimism.
    Lancet. 2020;396:867.
    >> Share

  983. JAFFE S
    Media reports reveal political interference at the US CDC.
    Lancet. 2020;396:875.
    >> Share

  984. BALL P
    David Hare's fiery account of COVID-19.
    Lancet. 2020;396:878-879.
    >> Share

  985. FLOWER B, Atchison C
    SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
    >> Share

  986. BARBARO RP, MacLaren G, Boonstra PS, Iwashyna TJ, et al
    Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32008.
    >> Share

  987. ANAND S, Montez-Rath M, Han J, Bozeman J, et al
    Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32009.
    >> Share

  988. HAN E, Tan MMJ, Turk E, Sridhar D, et al
    Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.
    Lancet. 2020 Sep 24. pii: S0140-6736(20)32007.
    >> Share

  989. LOGUNOV DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31970.
    >> Share

  990. PEIRIS M, Leung GM
    What can we expect from first-generation COVID-19 vaccines?
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31976.
    >> Share

  991. BUCCI E, Andreev K, Bjorkman A, Calogero RA, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31960.
    >> Share

  992. MARINHO PM, Nascimento H, Marcos AAA, Romano AC, et al
    Seeking clarity on retinal findings in patients with COVID-19 - Authors' reply.
    Lancet. 2020;396:e40.
    >> Share

  993. DUH EJ
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e39.
    >> Share

  994. COLLISON FT, Carroll J
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e38.
    >> Share

  995. BRANDAO-DE-RESENDE C, Diniz-Filho A, Vasconcelos-Santos DV
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e37.
    >> Share

  996. VENKATESH P
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e36.
    >> Share

  997. OUYANG P, Zhang X, Peng Y, Jiang B, et al
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e35.
    >> Share

  998. PONTES MRN, Lima JP
    Brazil's COVID-19 response.
    Lancet. 2020;396:e34.
    >> Share

  999. RIZZO LV, Wolosker N
    Brazil's COVID-19 response.
    Lancet. 2020;396:e33.
    >> Share

  1000. VALENTE DS, Zanella RK
    Brazil's COVID-19 response.
    Lancet. 2020;396:e32.
    >> Share

  1001. DA SILVA BASTOS MH
    Brazil's COVID-19 response.
    Lancet. 2020;396:e31.
    >> Share

  1002. DE ANDREAZZI CS, Brandao ML, Bueno MG, Winck GR, et al
    Brazil's COVID-19 response.
    Lancet. 2020;396:e30.
    >> Share

  1003. AGREN D
    Understanding Mexican health worker COVID-19 deaths.
    Lancet. 2020;396:807.
    >> Share

  1004. THE LANCET
    COVID-19: a stress test for trust in science.
    Lancet. 2020;396:799.
    >> Share

  1005. KLEINERT S, Horton R
    Preprints with The Lancet are here to stay.
    Lancet. 2020;396:805.
    >> Share

  1006. JONES D, Helmreich S
    A history of herd immunity.
    Lancet. 2020;396:810-811.
    >> Share

  1007. GALEA S, Ettman CK, Abdalla SM
    Access to health care and the 2020 US election.
    Lancet. 2020;396:803-805.
    >> Share


  1008. Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31927.
    >> Share

  1009. SLIWA K, Yacoub M
    Catalysing the response to NCDI Poverty at a time of COVID-19.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31911.
    >> Share

  1010. THE LANCET
    Global collaboration for health: rhetoric versus reality.
    Lancet. 2020;396:735.
    >> Share

  1011. PHELAN AL, Eccleston-Turner M, Rourke M, Maleche A, et al
    Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access.
    Lancet. 2020 Sep 7. pii: S0140-6736(20)31873.
    >> Share

  1012. DEVI S
    COVID-19 exacerbates violence against health workers.
    Lancet. 2020;396:658.
    >> Share

  1013. CHATTERJEE P
    Is India missing COVID-19 deaths?
    Lancet. 2020;396:657.
    >> Share

  1014. THE LANCET
    COVID-19: a new lens for non-communicable diseases.
    Lancet. 2020;396:649.
    >> Share

  1015. OLDENBURG CE, Doan T
    Azithromycin for severe COVID-19.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31863.
    >> Share

  1016. FURTADO RHM, Berwanger O, Fonseca HA, Correa TD, et al
    Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31862.
    >> Share

  1017. LOGUNOV DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, et al
    Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31866.
    >> Share

  1018. BAR-ZEEV N, Inglesby T
    COVID-19 vaccines: early success and remaining challenges.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31867.
    >> Share

  1019. ALICANDRO G, Remuzzi G, La Vecchia C
    Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31865.
    >> Share

  1020. KOCA F
    Promotion of scientific research on COVID-19 in Turkey.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31864.
    >> Share

    August 2020
  1021. MCLENNAN AK, Hansen AKK, Ulijaszek SJ
    Health and medicine cannot solve COVID-19.
    Lancet. 2020;396:599-600.
    >> Share

  1022. COUSINS S
    Bangladesh's COVID-19 testing criticised.
    Lancet. 2020;396:591.
    >> Share

  1023. THE LANCET
    Research and higher education in the time of COVID-19.
    Lancet. 2020;396:583.
    >> Share

  1024. FISHER DA, Carson G
    Back to basics: the outbreak response pillars.
    Lancet. 2020;396:598.
    >> Share

  1025. ROSADAS C, Randell P, Khan M, McClure MO, et al
    Testing for responses to the wrong SARS-CoV-2 antigen?
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31830.
    >> Share

  1026. KRAUSE P, Fleming TR, Longini I, Henao-Restrepo AM, et al
    COVID-19 vaccine trials should seek worthwhile efficacy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31821.
    >> Share

  1027. DASHRAATH P, Nielsen-Saines K, Madhi SA, Baud D, et al
    COVID-19 vaccines and neglected pregnancy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31822.
    >> Share

  1028. ALWAN NA
    Surveillance is underestimating the burden of the COVID-19 pandemic.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31823.
    >> Share

  1029. VAN DORN A
    COVID-19 and readjusting clinical trials.
    Lancet. 2020;396:523-524.
    >> Share

  1030. MAUVAIS-JARVIS F, Bairey Merz N, Barnes PJ, Brinton RD, et al
    Sex and gender: modifiers of health, disease, and medicine.
    Lancet. 2020;396:565-582.
    >> Share

  1031. THE LANCET
    Trump versus Biden: a fight for the health of a nation.
    Lancet. 2020;396:513.
    >> Share

  1032. VERKUIL LD, Liu GT, Brahma VL, Avery RA, et al
    Pseudotumor cerebri syndrome associated with MIS-C: a case report.
    Lancet. 2020;396:532.
    >> Share

  1033. YOUNG BE, Fong SW, Chan YH, Mak TM, et al
    Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
    Lancet. 2020 Aug 18. pii: S0140-6736(20)31757.
    >> Share

  1034. BUSE K, Nilo A, Kim J, Heywood M, et al
    COVID-19 combination prevention requires attention to structural drivers.
    Lancet. 2020;396:466.
    >> Share

  1035. MANARA AR, Mumford L, Callaghan CJ, Ravanan R, et al
    Donation and transplantation activity in the UK during the COVID-19 lockdown.
    Lancet. 2020;396:465-466.
    >> Share

  1036. BAYRAM H, Kokturk N, Elbek O, Kilinc O, et al
    Interference in scientific research on COVID-19 in Turkey.
    Lancet. 2020;396:463-464.
    >> Share

  1037. WATT RG
    COVID-19 is an opportunity for reform in dentistry.
    Lancet. 2020;396:462.
    >> Share

  1038. GERTNER E
    COVID-19 trial co-enrolment and subsequent enrolment.
    Lancet. 2020;396:461-462.
    >> Share

  1039. MAKONI M
    COVID-19 worsens Zimbabwe's health crisis.
    Lancet. 2020;396:457.
    >> Share

  1040. PEETERS A, Mullins G, Becker D, Orellana L, et al
    COVID-19's impact on Australia's health research workforce.
    Lancet. 2020;396:461.
    >> Share

  1041. THE LANCET
    Humanitarian crises in a global pandemic.
    Lancet. 2020;396:447.
    >> Share

  1042. BRAUN F, Lutgehetmann M, Pfefferle S, Wong MN, et al
    SARS-CoV-2 renal tropism associates with acute kidney injury.
    Lancet. 2020 Aug 14. pii: S0140-6736(20)31759.
    >> Share

  1043. JAMIOLKOWSKI D, Muhleisen B, Muller S, Navarini AA, et al
    SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report.
    Lancet. 2020 Aug 13. pii: S0140-6736(20)31754.
    >> Share

  1044. BHOPAL SS, Bhopal R
    Sex differential in COVID-19 mortality varies markedly by age.
    Lancet. 2020 Aug 13. pii: S0140-6736(20)31748.
    >> Share

  1045. AIYEGBUSI OL, Calvert MJ
    Patient-reported outcomes: central to the management of COVID-19.
    Lancet. 2020 Aug 10. pii: S0140-6736(20)31724.
    >> Share

  1046. GIESECKE J
    COVID-19-a very visible pandemic - Author's reply.
    Lancet. 2020;396:e20.
    >> Share

  1047. KEIL EJ
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e19.
    >> Share

  1048. EWING A
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e18.
    >> Share

  1049. DURRHEIM DN, Baker MG
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e17.
    >> Share

  1050. LINDAHL JF, Olsen B, Lundkvist A
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e16.
    >> Share

  1051. KING C, Einhorn L, Brusselaers N, Carlsson M, et al
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e15.
    >> Share

  1052. RAMACHANDRAN R
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e13-e14.
    >> Share

  1053. DEVI S
    Egyptian health workers arrested after COVID-19 comments.
    Lancet. 2020;396:369.
    >> Share

  1054. CROVETTO F, Crispi F, Llurba E, Figueras F, et al
    Seroprevalence and presentation of SARS-CoV-2 in pregnancy.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31714.
    >> Share

  1055. FANCOURT D, Steptoe A, Wright L
    The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31690.
    >> Share

  1056. GARCIA-BASTEIRO A, Alvarez-Dardet C, Arenas A, Bengoa R, et al
    The need for an independent evaluation of the COVID-19 response in Spain.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31713.
    >> Share

  1057. ANDERSON RM, Hollingsworth TD, Baggaley RF, Maddren R, et al
    COVID-19 spread in the UK: the end of the beginning?
    Lancet. 2020 Aug 3. pii: S0140-6736(20)31689.
    >> Share

  1058. COUSINS S
    COVID-19 has "devastating" effect on women and girls.
    Lancet. 2020;396:301-302.
    >> Share

  1059. THE LANCET
    The truth is out there, somewhere.
    Lancet. 2020;396:291.
    >> Share

  1060. GOSTIN LO, Koh HH, Williams M, Hamburg MA, et al
    US withdrawal from WHO is unlawful and threatens global and US health and security.
    Lancet. 2020;396:293-295.
    >> Share

    July 2020
  1061. BARBERIA LG, Gomez EJ
    Political and institutional perils of Brazil's COVID-19 crisis.
    Lancet. 2020 Jul 30. pii: S0140-6736(20)31681.
    >> Share

  1062. HEADEY D, Heidkamp R, Osendarp S, Ruel M, et al
    Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality.
    Lancet. 2020 Jul 27. pii: S0140-6736(20)31647.
    >> Share

  1063. FORE HH, Dongyu Q, Beasley DM, Ghebreyesus TA, et al
    Child malnutrition and COVID-19: the time to act is now.
    Lancet. 2020 Jul 27. pii: S0140-6736(20)31648.
    >> Share

  1064. KARIM SA
    COVID-19 vaccine affordability and accessibility.
    Lancet. 2020;396:238.
    >> Share

  1065. EADES S, Eades F, McCaullay D, Nelson L, et al
    Australia's First Nations' response to the COVID-19 pandemic.
    Lancet. 2020;396:237-238.
    >> Share

  1066. DANIELS JP
    COVID-19 cases surge in Colombia.
    Lancet. 2020;396:227.
    >> Share

  1067. HORTON R
    Offline: Preparing for a vaccine against COVID-19.
    Lancet. 2020;396:226.
    >> Share

  1068. LANCET T
    COVID-19 and China: lessons and the way forward.
    Lancet. 2020;396:213.
    >> Share

  1069. PHUMAPHI J, Mason E, Alipui NK, Cisnero JR, et al
    A crisis of accountability for women's, children's, and adolescents' health.
    Lancet. 2020;396:222-224.
    >> Share

  1070. RUSHTON CH, Doerries B, Greene J, Geller G, et al
    Dramatic interventions in the tragedy of the COVID-19 pandemic.
    Lancet. 2020 Jul 23. pii: S0140-6736(20)31641.
    >> Share

  1071. BAR-ZEEV N, Moss WJ
    Encouraging results from phase 1/2 COVID-19 vaccine trials.
    Lancet. 2020 Jul 20. pii: S0140-6736(20)31611.
    >> Share

  1072. ZHU FC, Guan XH, Li YH, Huang JY, et al
    Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2020 Jul 20. pii: S0140-6736(20)31605.
    >> Share

  1073. FOLEGATTI PM, Ewer KJ, Aley PK, Angus B, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
    Lancet. 2020 Jul 20. pii: S0140-6736(20)31604.
    >> Share

  1074. HORTON R
    Offline: COVID-19 and the dangers of Sinophobia.
    Lancet. 2020;396:154.
    >> Share

  1075. RUTTER H, Horton R, Marteau TM
    The Lancet-Chatham House Commission on improving population health post COVID-19.
    Lancet. 2020;396:152-153.
    >> Share

  1076. NEPOMNYASHCHIY L, Dahn B, Saykpah R, Raghavan M, et al
    COVID-19: Africa needs unprecedented attention to strengthen community health systems.
    Lancet. 2020;396:150-152.
    >> Share

  1077. IWAI Y, Khan ZH, DasGupta S
    Abolition medicine.
    Lancet. 2020;396:158-159.
    >> Share

  1078. USHER AD
    New funds proposed to prevent pandemics.
    Lancet. 2020;396:155.
    >> Share

  1079. THE LANCET
    No more normal.
    Lancet. 2020;396:143.
    >> Share

  1080. ROLLSTON R, Wilkinson E, Abouelazm R, Mladenov P, et al
    Comprehensive sexuality education to address gender-based violence.
    Lancet. 2020;396:148-150.
    >> Share

  1081. BRADLEY BT, Maioli H, Johnston R, Chaudhry I, et al
    Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
    Lancet. 2020 Jul 16. pii: S0140-6736(20)31305.
    >> Share

  1082. NORTON A, Mphahlele J, Yazdanpanah Y, Piot P, et al
    Strengthening the global effort on COVID-19 research.
    Lancet. 2020 Jul 16. pii: S0140-6736(20)31598.
    >> Share

  1083. ATLANI-DUAULT L, Chauvin F, Yazdanpanah Y, Lina B, et al
    France's COVID-19 response: balancing conflicting public health traditions.
    Lancet. 2020 Jul 16. pii: S0140-6736(20)31599.
    >> Share

  1084. FISHER D, Teo YY, Nabarro D
    Assessing national performance in response to COVID-19.
    Lancet. 2020 Jul 15. pii: S0140-6736(20)31601.
    >> Share

  1085. MAFHAM MM, Spata E, Goldacre R, Gair D, et al
    COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.
    Lancet. 2020 Jul 14. pii: S0140-6736(20)31356.
    >> Share

  1086. THE LANCET
    COVID-19: the worst may be yet to come.
    Lancet. 2020;396:71.
    >> Share

  1087. GILL D, Whitehead C, Wondimagegn D
    Challenges to medical education at a time of physical distancing.
    Lancet. 2020;396:77-79.
    >> Share

  1088. CAREL H, Ratcliffe M, Froese T
    Reflecting on experiences of social distancing.
    Lancet. 2020;396:87-88.
    >> Share

  1089. ALJAYYOUSSI G
    The harms of police frisking in times of a pandemic.
    Lancet. 2020;396:91.
    >> Share

  1090. LOTTA G, Wenham C, Nunes J, Pimenta DN, et al
    Community health workers reveal COVID-19 disaster in Brazil.
    Lancet. 2020 Jul 10. pii: S0140-6736(20)31521.
    >> Share

  1091. SHAIGANY S, Gnirke M, Guttmann A, Chong H, et al
    An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
    Lancet. 2020 Jul 10. pii: S0140-6736(20)31526.
    >> Share

  1092. KIRSCHENBAUM D, Imbach LL, Ulrich S, Rushing EJ, et al
    Inflammatory olfactory neuropathy in two patients with COVID-19.
    Lancet. 2020 Jul 10. pii: S0140-6736(20)31525.
    >> Share

  1093. SACHS JD, Horton R, Bagenal J, Amor YB, et al
    The Lancet COVID-19 Commission.
    Lancet. 2020 Jul 9. pii: S0140-6736(20)31494.
    >> Share

  1094. FUNCK-BRENTANO C, Nguyen LS, Salem JE
    Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19.
    Lancet. 2020 Jul 9. pii: S0140-6736(20)31528.
    >> Share

  1095. HOULIHAN CF, Vora N, Byrne T, Lewer D, et al
    Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.
    Lancet. 2020 Jul 9. pii: S0140-6736(20)31484.
    >> Share

  1096. WANG HH, Lau E, Horton R
    The Wakley-Wu Lien Teh Prize Essay 2020: Chinese health workers' experiences during the COVID-19 pandemic.
    Lancet. 2020;396:13.
    >> Share

  1097. ECKERLE I, Meyer B
    SARS-CoV-2 seroprevalence in COVID-19 hotspots.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31482.
    >> Share

  1098. POLLAN M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, et al
    Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31483.
    >> Share

  1099. AL SAIDI AMO, Nur FA, Al-Mandhari AS, El Rabbat M, et al
    Decisive leadership is a necessity in the COVID-19 response.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31493.
    >> Share

  1100. KAVANAGH MM, Katz IT, Holmes CB
    Reckoning with mortality: global health, HIV, and the politics of data.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31046.
    >> Share

  1101. NAZARETH J, Minhas JS, Jenkins DR, Sahota A, et al
    Early lessons from a second COVID-19 lockdown in Leicester, UK.
    Lancet. 2020 Jul 2. pii: S0140-6736(20)31490.
    >> Share


  1102. After COVID-19, a future for the world's children?
    Lancet. 2020 Jul 2. pii: S0140-6736(20)31481.
    >> Share

  1103. KING A, Andrus JK, Figueroa JP
    Financial crisis at PAHO in the time of COVID-19: a call for action.
    Lancet. 2020 Jul 2. pii: S0140-6736(20)31489.
    >> Share

    June 2020
  1104. GNECCHI M, Moretti F, Bassi EM, Leonardi S, et al
    Myocarditis in a 16-year-old boy positive for SARS-CoV-2.
    Lancet. 2020;395:e116.
    >> Share

  1105. DEVI S
    Access to health care under threat in Afghanistan.
    Lancet. 2020;395:1962.
    >> Share

  1106. BANG A
    Faced with today's crisis, what would Gandhi do?
    Lancet. 2020;395:e114-e115.
    >> Share

  1107. DEVAKUMAR D, Selvarajah S, Shannon G, Muraya K, et al
    Racism, the public health crisis we can no longer ignore.
    Lancet. 2020;395:e112-e113.
    >> Share

  1108. THE LANCET
    Generation coronavirus?
    Lancet. 2020;395:1949.
    >> Share

  1109. MARCHALIK D, Petrov D
    Seeing COVID-19 through Jose Saramago's Blindness.
    Lancet. 2020;395:1899.
    >> Share

  1110. DEVI S
    COVID-19 resurgence in Iran.
    Lancet. 2020;395:1896.
    >> Share

  1111. BAKER P, White A, Morgan R
    Men's health: COVID-19 pandemic highlights need for overdue policy action.
    Lancet. 2020;395:1886-1888.
    >> Share

  1112. THE LANCET
    Global governance for COVID-19 vaccines.
    Lancet. 2020;395:1883.
    >> Share

  1113. KING T, Hewitt B, Crammond B, Sutherland G, et al
    Reordering gender systems: can COVID-19 lead to improved gender equality and health?
    Lancet. 2020 Jun 19. pii: S0140-6736(20)31418.
    >> Share

  1114. TAYLOR AL, Habibi R, Burci GL, Dagron S, et al
    Solidarity in the wake of COVID-19: reimagining the International Health Regulations.
    Lancet. 2020 Jun 19. pii: S0140-6736(20)31417.
    >> Share

  1115. RAVI K
    Ethnic disparities in COVID-19 mortality: are comorbidities to blame?
    Lancet. 2020 Jun 19. pii: S0140-6736(20)31423.
    >> Share

  1116. GABSTER BP, van Daalen K, Dhatt R, Barry M, et al
    Challenges for the female academic during the COVID-19 pandemic.
    Lancet. 2020 Jun 18. pii: S0140-6736(20)31412.
    >> Share

  1117. SIPIDO KR, Antonanzas F, Celis J, Degos L, et al
    Overcoming fragmentation of health research in Europe: lessons from COVID-19.
    Lancet. 2020 Jun 16. pii: S0140-6736(20)31411.
    >> Share

  1118. USHER AD
    COVID-19 vaccines for all?
    Lancet. 2020;395:1822-1823.
    >> Share

  1119. HORTON R
    Offline: COVID-19-what we can expect to come.
    Lancet. 2020;395:1821.
    >> Share

  1120. NAY O, Kieny MP, Marmora L, Kazatchkine M, et al
    The WHO we want.
    Lancet. 2020;395:1818-1820.
    >> Share

  1121. BURZYNSKA K, Contreras G
    Gendered effects of school closures during the COVID-19 pandemic.
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31377.
    >> Share

  1122. TREWEEK S, Forouhi NG, Narayan KMV, Khunti K, et al
    COVID-19 and ethnicity: who will research results apply to?
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31380.
    >> Share

  1123. MULLER JE, Nathan DG
    COVID-19, nuclear war, and global warming: lessons for our vulnerable world.
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31379.
    >> Share

  1124. OKELL LC, Verity R, Watson OJ, Mishra S, et al
    Have deaths from COVID-19 in Europe plateaued due to herd immunity?
    Lancet. 2020 Jun 11. pii: S0140-6736(20)31357.
    >> Share

  1125. STRINGHINI S, Wisniak A, Piumatti G, Azman AS, et al
    Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
    Lancet. 2020 Jun 11. pii: S0140-6736(20)31304.
    >> Share

  1126. LI X, Krumholz HM, Yip W, Cheng KK, et al
    Quality of primary health care in China: challenges and recommendations.
    Lancet. 2020;395:1802-1812.
    >> Share

  1127. CURTICE K, Choo E
    Indigenous populations: left behind in the COVID-19 response.
    Lancet. 2020;395:1753.
    >> Share

  1128. MULLARD A
    COVID-19 vaccine development pipeline gears up.
    Lancet. 2020;395:1751-1752.
    >> Share

  1129. HORTON R
    Offline: COVID-19 and the ethics of memory.
    Lancet. 2020;395:1750.
    >> Share

  1130. THE LANCET
    Salient lessons from Russia's COVID-19 outbreak.
    Lancet. 2020;395:1739.
    >> Share

  1131. MEHRA MR, Ruschitzka F, Patel AN
    Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
    Lancet. 2020 Jun 5. pii: S0140-6736(20)31324.
    >> Share

  1132. VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
    Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
    Lancet. 2020 Jun 4. pii: S0140-6736(20)31282.
    >> Share

  1133. MENNI C, Sudre CH, Steves CJ, Ourselin S, et al
    Quantifying additional COVID-19 symptoms will save lives.
    Lancet. 2020 Jun 4. pii: S0140-6736(20)31281.
    >> Share

  1134. LI Z, Chen Q, Feng L, Rodewald L, et al
    Active case finding with case management: the key to tackling the COVID-19 pandemic.
    Lancet. 2020 Jun 4. pii: S0140-6736(20)31278.
    >> Share

  1135. THE LANCET EDITORS
    Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
    Lancet. 2020 Jun 3. pii: S0140-6736(20)31290.
    >> Share

  1136. MACINTYRE CR, Wang Q
    Physical distancing, face masks, and eye protection for prevention of COVID-19.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31183.
    >> Share

  1137. CHU DK, Akl EA, Duda S, Solo K, et al
    Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31142.
    >> Share

  1138. CHAN EYY, Gobat N, Kim JH, Newnham EA, et al
    Informal home care providers: the forgotten health-care workers during the COVID-19 pandemic.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31254.
    >> Share

    May 2020
  1139. FRASER B
    COVID-19 strains remote regions of Peru.
    Lancet. 2020;395:1684.
    >> Share

  1140. DEVI S
    Fears of "highly catastrophic" COVID-19 spread in Yemen.
    Lancet. 2020;395:1683.
    >> Share

  1141. HORTON R
    Offline: After COVID-19-is an "alternate society" possible?
    Lancet. 2020;395:1682.
    >> Share

  1142. THE LANCET
    COVID-19 in Africa: no room for complacency.
    Lancet. 2020;395:1669.
    >> Share

  1143. MARSTON C, Renedo A, Miles S
    Community participation is crucial in a pandemic.
    Lancet. 2020;395:1676-1678.
    >> Share

  1144. CASH R, Patel V
    Has COVID-19 subverted global health?
    Lancet. 2020;395:1687-1688.
    >> Share

  1145. GIESECKE J
    The invisible pandemic.
    Lancet. 2020;395:e98.
    >> Share


  1146. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.
    Lancet. 2020 May 29. pii: S0140-6736(20)31182.
    >> Share

  1147. PURAS D, de Mesquita JB, Cabal L, Maleche A, et al
    The right to health must guide responses to COVID-19.
    Lancet. 2020 May 29. pii: S0140-6736(20)31255.
    >> Share

  1148. POORTMANS PM, Guarneri V, Cardoso MJ
    Cancer and COVID-19: what do we really know?
    Lancet. 2020 May 29. pii: S0140-6736(20)31240.
    >> Share

  1149. MYLES PS, Maswime S
    Mitigating the risks of surgery during the COVID-19 pandemic.
    Lancet. 2020 May 29. pii: S0140-6736(20)31256.
    >> Share

  1150. LEE LYW, Cazier JB, Starkey T, Turnbull CD, et al
    COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
    Lancet. 2020 May 28. pii: S0140-6736(20)31173.
    >> Share

  1151. KUDERER NM, Choueiri TK, Shah DP, Shyr Y, et al
    Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
    Lancet. 2020 May 28. pii: S0140-6736(20)31187.
    >> Share

  1152. LEE N, McGeer A
    The starting line for COVID-19 vaccine development.
    Lancet. 2020 May 28. pii: S0140-6736(20)31239.
    >> Share

  1153. BANATVALA J
    COVID-19 testing delays and pathology services in the UK.
    Lancet. 2020 May 27. pii: S0140-6736(20)31037.
    >> Share

  1154. KRIEGER N, Chen JT, Waterman PD
    Excess mortality in men and women in Massachusetts during the COVID-19 pandemic.
    Lancet. 2020 May 27. pii: S0140-6736(20)31234.
    >> Share

  1155. ALLEN M, Braithwaite I, Collinson S, Oskrochi Y, et al
    A view from UK public health registrars on the challenges of COVID-19.
    Lancet. 2020 May 27. pii: S0140-6736(20)31058.
    >> Share

  1156. STRUWE W, Emmott E, Bailey M, Sharon M, et al
    The COVID-19 MS Coalition-accelerating diagnostics, prognostics, and treatment.
    Lancet. 2020 May 27. pii: S0140-6736(20)31211.
    >> Share

  1157. TANG C, Wang Y, Lv H, Guan Z, et al
    Caution against corticosteroid-based COVID-19 treatment.
    Lancet. 2020 May 25. pii: S0140-6736(20)30749.
    >> Share


  1158. Assistance Publique-Hopitaux de Paris' response to the COVID-19 pandemic.
    Lancet. 2020 May 25. pii: S0140-6736(20)31210.
    >> Share

  1159. MAIER CL, Truong AD, Auld SC, Polly DM, et al
    COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
    Lancet. 2020 May 25. pii: S0140-6736(20)31209.
    >> Share

  1160. HORTON R
    Offline: Health in the unhappy time of COVID-19.
    Lancet. 2020;395:1600.
    >> Share

  1161. THE LANCET
    The plight of essential workers during the COVID-19 pandemic.
    Lancet. 2020;395:1587.
    >> Share

  1162. SAINI A
    Stereotype threat.
    Lancet. 2020;395:1604-1605.
    >> Share

  1163. LANE R
    Helena Legido-Quigley: proponent of health systems strengthening.
    Lancet. 2020;395:1603.
    >> Share

  1164. BURKI T
    England and Wales see 20 000 excess deaths in care homes.
    Lancet. 2020;395:1602.
    >> Share

  1165. AGREN D
    Mexican President Lopez Obrador draws doctors' ire.
    Lancet. 2020;395:1601.
    >> Share

  1166. FUNCK-BRENTANO C, Salem JE
    Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
    Lancet. 2020 May 22. pii: S0140-6736(20)31174.
    >> Share

  1167. GALEA S
    Compassion in a time of COVID-19.
    Lancet. 2020 May 22. pii: S0140-6736(20)31202.
    >> Share

  1168. MEHRA MR, Desai SS, Ruschitzka F, Patel AN, et al
    Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
    Lancet. 2020 May 22. pii: S0140-6736(20)31180.
    >> Share

  1169. ZHU FC, Li YH, Guan XH, Hou LH, et al
    Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
    Lancet. 2020 May 22. pii: S0140-6736(20)31208.
    >> Share

  1170. GROSS R, Conzelmann C, Muller JA, Stenger S, et al
    Detection of SARS-CoV-2 in human breastmilk.
    Lancet. 2020 May 21. pii: S0140-6736(20)31181.
    >> Share

  1171. MCKAY D, Heisler M, Mishori R, Catton H, et al
    Attacks against health-care personnel must stop, especially as the world fights COVID-19.
    Lancet. 2020 May 20. pii: S0140-6736(20)31191.
    >> Share

  1172. GRASSELLI G, Zanella A
    Critically ill patients with COVID-19 in New York City.
    Lancet. 2020 May 19. pii: S0140-6736(20)31190.
    >> Share

  1173. GOLDSMITH CS, Miller SE, Martines RB, Bullock HA, et al
    Electron microscopy of SARS-CoV-2: a challenging task.
    Lancet. 2020 May 19. pii: S0140-6736(20)31188.
    >> Share

  1174. CUMMINGS MJ, Baldwin MR, Abrams D, Jacobson SD, et al
    Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
    Lancet. 2020 May 19. pii: S0140-6736(20)31189.
    >> Share

  1175. VARGA Z, Flammer AJ, Steiger P, Haberecker M, et al
    Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.
    Lancet. 2020 May 19. pii: S0140-6736(20)31185.
    >> Share

  1176. GROSS O, Moerer O, Weber M, Huber TB, et al
    COVID-19-associated nephritis: early warning for disease severity and complications?
    Lancet. 2020;395:e87-e88.
    >> Share

  1177. CUADRADO-PAYAN E, Montagud-Marrahi E, Torres-Elorza M, Bodro M, et al
    SARS-CoV-2 and influenza virus co-infection.
    Lancet. 2020;395:e84.
    >> Share

  1178. LEVERENZ DL, Tarrant TK
    Is the HScore useful in COVID-19?
    Lancet. 2020;395:e83.
    >> Share

  1179. WANG Y, Zhang D, Du G, Du R, et al
    Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Lancet. 2020;395:1569-1578.
    >> Share

  1180. PERINI P, Nabulsi B, Massoni CB, Azzarone M, et al
    Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19.
    Lancet. 2020;395:1546.
    >> Share

  1181. OKANO JT, Blower S
    Preventing major outbreaks of COVID-19 in jails.
    Lancet. 2020;395:1542-1543.
    >> Share

  1182. DICKENS BL, Koo JR, Wilder-Smith A, Cook AR, et al
    Institutional, not home-based, isolation could contain the COVID-19 outbreak.
    Lancet. 2020;395:1541-1542.
    >> Share

  1183. NORRIE JD
    Remdesivir for COVID-19: challenges of underpowered studies.
    Lancet. 2020;395:1525-1527.
    >> Share

  1184. HORTON R
    Offline: Don't let COVID-19 divert us completely.
    Lancet. 2020;395:1534.
    >> Share

  1185. AMUASI JH, Walzer C, Heymann D, Carabin H, et al
    Calling for a COVID-19 One Health Research Coalition.
    Lancet. 2020;395:1543-1544.
    >> Share

  1186. THORNTON J
    In the aftermath: the legacy of measles in Samoa.
    Lancet. 2020;395:1535-1536.
    >> Share

  1187. THE LANCET
    Reviving the US CDC.
    Lancet. 2020;395:1521.
    >> Share

  1188. BREWSTER CT, Choong J, Thomas C, Wilson D, et al
    Steam inhalation and paediatric burns during the COVID-19 pandemic.
    Lancet. 2020 May 15. pii: S0140-6736(20)31144.
    >> Share

  1189. KAPLAN HS, Trumble BC, Stieglitz J, Mamany RM, et al
    Voluntary collective isolation as a best response to COVID-19 for indigenous populations? A case study and protocol from the Bolivian Amazon.
    Lancet. 2020 May 15. pii: S0140-6736(20)31104.
    >> Share

  1190. YANG Y
    Use of herbal drugs to treat COVID-19 should be with caution.
    Lancet. 2020 May 15. pii: S0140-6736(20)31143.
    >> Share

  1191. PLATT L, Elmes J, Stevenson L, Holt V, et al
    Sex workers must not be forgotten in the COVID-19 response.
    Lancet. 2020 May 15. pii: S0140-6736(20)31033.
    >> Share

  1192. CHIRIBOGA D, Garay J, Buss P, Madrigal RS, et al
    Health inequity during the COVID-19 pandemic: a cry for ethical global leadership.
    Lancet. 2020 May 15. pii: S0140-6736(20)31145.
    >> Share

  1193. LEE K, Worsnop CZ, Grepin KA, Kamradt-Scott A, et al
    Global coordination on cross-border travel and trade measures crucial to COVID-19 response.
    Lancet. 2020 May 14. pii: S0140-6736(20)31032.
    >> Share

  1194. HOLMES JL, Brake S, Docherty M, Lilford R, et al
    Emergency ambulance services for heart attack and stroke during UK's COVID-19 lockdown.
    Lancet. 2020 May 14. pii: S0140-6736(20)31031.
    >> Share

  1195. WILLIAMS B, Zhang Y
    Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19.
    Lancet. 2020 May 14. pii: S0140-6736(20)31131.
    >> Share

  1196. DE ABAJO FJ, Rodriguez-Martin S, Lerma V, Mejia-Abril G, et al
    Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
    Lancet. 2020 May 14. pii: S0140-6736(20)31030.
    >> Share

  1197. GONDI S, Beckman AL, Deveau N, Raja AS, et al
    Personal protective equipment needs in the USA during the COVID-19 pandemic.
    Lancet. 2020 May 14. pii: S0140-6736(20)31038.
    >> Share

  1198. VERDONI L, Mazza A, Gervasoni A, Martelli L, et al
    An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
    Lancet. 2020 May 13. pii: S0140-6736(20)31103.
    >> Share

  1199. VINER RM, Whittaker E
    Kawasaki-like disease: emerging complication during the COVID-19 pandemic.
    Lancet. 2020 May 13. pii: S0140-6736(20)31129.
    >> Share

  1200. WHITEHEAD CL, Walker SP
    Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Lancet. 2020 May 13. pii: S0140-6736(20)31029.
    >> Share

  1201. JORDANA J, Trivino-Salazar JC
    Where are the ECDC and the EU-wide responses in the COVID-19 pandemic?
    Lancet. 2020 May 13. pii: S0140-6736(20)31132.
    >> Share

  1202. MARINHO PM, Marcos AAA, Romano AC, Nascimento H, et al
    Retinal findings in patients with COVID-19.
    Lancet. 2020 May 12. pii: S0140-6736(20)31014.
    >> Share

  1203. DIVALA T, Burke RM, Ndeketa L, Corbett EL, et al
    Africa faces difficult choices in responding to COVID-19.
    Lancet. 2020 May 12. pii: S0140-6736(20)31056.
    >> Share

  1204. BANERJEE A, Pasea L, Harris S, Gonzalez-Izquierdo A, et al
    Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.
    Lancet. 2020 May 12. pii: S0140-6736(20)30854.
    >> Share

  1205. LOUPY A, Aubert O, Reese PP, Bastien O, et al
    Organ procurement and transplantation during the COVID-19 pandemic.
    Lancet. 2020 May 11. pii: S0140-6736(20)31040.
    >> Share

  1206. COUSINS S
    New Zealand eliminates COVID-19.
    Lancet. 2020;395:1474.
    >> Share

  1207. FRASER B
    Chile plans controversial COVID-19 certificates.
    Lancet. 2020;395:1473.
    >> Share

  1208. HORTON R
    Offline: Independent science advice for COVID-19-at last.
    Lancet. 2020;395:1472.
    >> Share

  1209. THE LANCET
    COVID-19 in Brazil: "So what?"
    Lancet. 2020;395:1461.
    >> Share

  1210. MCENROE N
    Celebrating Florence Nightingale's bicentenary.
    Lancet. 2020;395:1475-1478.
    >> Share

  1211. AMUASI JH, Lucas T, Horton R, Winkler AS, et al
    Reconnecting for our future: The Lancet One Health Commission.
    Lancet. 2020;395:1469-1471.
    >> Share

  1212. BHALA N, Curry G, Martineau AR, Agyemang C, et al
    Sharpening the global focus on ethnicity and race in the time of COVID-19.
    Lancet. 2020 May 8. pii: S0140-6736(20)31102.
    >> Share

  1213. HUNG IF, Lung KC, Tso EY, Liu R, et al
    Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
    Lancet. 2020 May 8. pii: S0140-6736(20)31042.
    >> Share

  1214. TREIBEL TA, Manisty C, Burton M, McKnight A, et al
    COVID-19: PCR screening of asymptomatic health-care workers at London hospital.
    Lancet. 2020 May 8. pii: S0140-6736(20)31100.
    >> Share

  1215. KLUGE HHP, Wickramasinghe K, Rippin HL, Mendes R, et al
    Prevention and control of non-communicable diseases in the COVID-19 response.
    Lancet. 2020 May 8. pii: S0140-6736(20)31067.
    >> Share

  1216. SHALHOUB S
    Interferon beta-1b for COVID-19.
    Lancet. 2020 May 8. pii: S0140-6736(20)31101.
    >> Share

  1217. RIPHAGEN S, Gomez X, Gonzalez-Martinez C, Wilkinson N, et al
    Hyperinflammatory shock in children during COVID-19 pandemic.
    Lancet. 2020 May 7. pii: S0140-6736(20)31094.
    >> Share

  1218. KAVANAGH MM, Erondu NA, Tomori O, Dzau VJ, et al
    Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics.
    Lancet. 2020 May 7. pii: S0140-6736(20)31093.
    >> Share

  1219. NOTT D
    The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises.
    Lancet. 2020 May 4. pii: S0140-6736(20)31036.
    >> Share

  1220. KASS DA, Duggal P, Cingolani O
    Obesity could shift severe COVID-19 disease to younger ages.
    Lancet. 2020 May 4. pii: S0140-6736(20)31024.
    >> Share

  1221. PANIZ-MONDOLFI AE, Sordillo EM, Marquez-Colmenarez MC, Delgado-Noguera LA, et al
    The arrival of SARS-CoV-2 in Venezuela.
    Lancet. 2020 May 4. pii: S0140-6736(20)31053.
    >> Share

  1222. PHELAN AL
    COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges.
    Lancet. 2020 May 4. pii: S0140-6736(20)31034.
    >> Share

  1223. MARMOT M
    Society and the slow burn of inequality.
    Lancet. 2020;395:1413-1414.
    >> Share

  1224. BURKI T
    Prisons are "in no way equipped" to deal with COVID-19.
    Lancet. 2020;395:1411-1412.
    >> Share

  1225. THE LANCET
    COVID-19: remaking the social contract.
    Lancet. 2020;395:1401.
    >> Share

  1226. SHIFFMAN J, Shawar YR
    Strengthening accountability of the global health metrics enterprise.
    Lancet. 2020;395:1452-1456.
    >> Share

    April 2020
  1227. CURTIS N, Sparrow A, Ghebreyesus TA, Netea MG, et al
    Considering BCG vaccination to reduce the impact of COVID-19.
    Lancet. 2020 Apr 30. pii: S0140-6736(20)31025.
    >> Share

  1228. POZNIAK A, Bekker LG, Kamarulzaman A, Gandhi M, et al
    A COVID-19 conference at AIDS 2020: Virtual.
    Lancet. 2020 Apr 30. pii: S0140-6736(20)31026.
    >> Share

  1229. ALTMANN DM, Douek DC, Boyton RJ
    What policy makers need to know about COVID-19 protective immunity.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30985.
    >> Share

  1230. AHMAD A, Chung R, Eckenwiler L, Ganguli AM, et al
    What does it mean to be made vulnerable in the era of COVID-19?
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30979.
    >> Share

  1231. NATHAN N, Prevost B, Corvol H
    Atypical presentation of COVID-19 in young infants.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30980.
    >> Share

  1232. PANCHAUD A, Favre G, Pomar L, Vouga M, et al
    An international registry for emergent pathogens and pregnancy.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30981.
    >> Share

  1233. CHOO EK
    COVID-19 fault lines.
    Lancet. 2020;395:1333.
    >> Share

  1234. DEVI S
    Travel restrictions hampering COVID-19 response.
    Lancet. 2020;395:1331-1332.
    >> Share

  1235. THE LANCET
    India under COVID-19 lockdown.
    Lancet. 2020;395:1315.
    >> Share

  1236. ORCUTT M, Patel P, Burns R, Hiam L, et al
    Global call to action for inclusion of migrants and refugees in the COVID-19 response.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30971.
    >> Share

  1237. DOYEN D, Moceri P, Ducreux D, Dellamonica J, et al
    Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30912.
    >> Share

  1238. RASMUSSEN S, Sperling P, Poulsen MS, Emmersen J, et al
    Medical students for health-care staff shortages during the COVID-19 pandemic.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30923.
    >> Share

  1239. HUNTER E, Price DA, Murphy E, van der Loeff IS, et al
    First experience of COVID-19 screening of health-care workers in England.
    Lancet. 2020 Apr 22. pii: S0140-6736(20)30970.
    >> Share

  1240. RADBRUCH L, Knaul FM, de Lima L, de Joncheere C, et al
    The key role of palliative care in response to the COVID-19 tsunami of suffering.
    Lancet. 2020 Apr 22. pii: S0140-6736(20)30964.
    >> Share

  1241. CARRABBA G, Tariciotti L, Guez S, Calderini E, et al
    Neurosurgery in an infant with COVID-19.
    Lancet. 2020 Apr 22. pii: S0140-6736(20)30927.
    >> Share

  1242. LEON DA, Shkolnikov VM, Smeeth L, Magnus P, et al
    COVID-19: a need for real-time monitoring of weekly excess deaths.
    Lancet. 2020 Apr 22. pii: S0140-6736(20)30933.
    >> Share

  1243. SPYROPOULOS AC, Ageno W, Barnathan ES
    Hospital-based use of thromboprophylaxis in patients with COVID-19.
    Lancet. 2020 Apr 21. pii: S0140-6736(20)30926.
    >> Share

  1244. PAREEK M, Bangash MN, Pareek N, Pan D, et al
    Ethnicity and COVID-19: an urgent public health research priority.
    Lancet. 2020 Apr 21. pii: S0140-6736(20)30922.
    >> Share

  1245. PETO J, Alwan NA, Godfrey KM, Burgess RA, et al
    Universal weekly testing as the UK COVID-19 lockdown exit strategy.
    Lancet. 2020 Apr 20. pii: S0140-6736(20)30936.
    >> Share

  1246. VARGA Z, Flammer AJ, Steiger P, Haberecker M, et al
    Endothelial cell infection and endotheliitis in COVID-19.
    Lancet. 2020 Apr 20. pii: S0140-6736(20)30937.
    >> Share

  1247. LANE R
    Sarah Gilbert: carving a path towards a COVID-19 vaccine.
    Lancet. 2020;395:1247.
    >> Share

  1248. MULLARD A
    Flooded by the torrent: the COVID-19 drug pipeline.
    Lancet. 2020;395:1245-1246.
    >> Share

  1249. DORN AV, Cooney RE, Sabin ML
    COVID-19 exacerbating inequalities in the US.
    Lancet. 2020;395:1243-1244.
    >> Share

  1250. THE LANCET
    Sustaining containment of COVID-19 in China.
    Lancet. 2020;395:1230.
    >> Share

  1251. THE LANCET
    COVID-19 in the USA: a question of time.
    Lancet. 2020;395:1229.
    >> Share

  1252. WHITE AIR
    Historical linkages: epidemic threat, economic risk, and xenophobia.
    Lancet. 2020;395:1250-1251.
    >> Share

  1253. LI H, Liu L, Zhang D, Xu J, et al
    SARS-CoV-2 and viral sepsis: observations and hypotheses.
    Lancet. 2020 Apr 17. pii: S0140-6736(20)30920.
    >> Share

  1254. CHENG KK, Lam TH, Leung CC
    Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity.
    Lancet. 2020 Apr 16. pii: S0140-6736(20)30918.
    >> Share

  1255. BLACK JRM, Bailey C, Swanton C
    COVID-19: the case for health-care worker screening to prevent hospital transmission.
    Lancet. 2020 Apr 16. pii: S0140-6736(20)30917.
    >> Share

  1256. ATKINSON B, Petersen E
    SARS-CoV-2 shedding and infectivity.
    Lancet. 2020 Apr 15. pii: S0140-6736(20)30868.
    >> Share

  1257. ZHOU F, Fan G, Liu Z, Cao B, et al
    SARS-CoV-2 shedding and infectivity - Authors' reply.
    Lancet. 2020 Apr 15. pii: S0140-6736(20)30869.
    >> Share

  1258. WEBSTER P
    Virtual health care in the era of COVID-19.
    Lancet. 2020;395:1180-1181.
    >> Share

  1259. JAFFE S
    Regulators split on antimalarials for COVID-19.
    Lancet. 2020;395:1179.
    >> Share

  1260. HORTON R
    Offline: COVID-19-bewilderment and candour.
    Lancet. 2020;395:1178.
    >> Share

  1261. HALL KS, Samari G, Garbers S, Casey SE, et al
    Centring sexual and reproductive health and justice in the global COVID-19 response.
    Lancet. 2020;395:1175-1177.
    >> Share

  1262. THE LANCET
    The gendered dimensions of COVID-19.
    Lancet. 2020;395:1168.
    >> Share

  1263. THE LANCET
    Palliative care and the COVID-19 pandemic.
    Lancet. 2020;395:1168.
    >> Share

  1264. FELDMANN M, Maini RN, Woody JN, Holgate ST, et al
    Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.
    Lancet. 2020 Apr 9. pii: S0140-6736(20)30858.
    >> Share

  1265. LEUNG K, Wu JT, Liu D, Leung GM, et al
    First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment.
    Lancet. 2020 Apr 8. pii: S0140-6736(20)30746.
    >> Share

  1266. TORRES I, Sacoto F
    Localising an asset-based COVID-19 response in Ecuador.
    Lancet. 2020 Apr 8. pii: S0140-6736(20)30851.
    >> Share

  1267. XU S, Li Y
    Beware of the second wave of COVID-19.
    Lancet. 2020 Apr 8. pii: S0140-6736(20)30845.
    >> Share

    March 2020
  1268. MCCARTNEY M
    Medicine: before COVID-19, and after.
    Lancet. 2020 Mar 31. pii: S0140-6736(20)30756.
    >> Share

  1269. YAMEY G, Schaferhoff M, Hatchett R, Pate M, et al
    Ensuring global access to COVID-19 vaccines.
    Lancet. 2020 Mar 31. pii: S0140-6736(20)30763.
    >> Share

  1270. KLUGE HHP, Jakab Z, Bartovic J, D'Anna V, et al
    Refugee and migrant health in the COVID-19 response.
    Lancet. 2020 Mar 31. pii: S0140-6736(20)30791.
    >> Share

  1271. WANG H, Li T, Barbarino P, Gauthier S, et al
    Dementia care during COVID-19.
    Lancet. 2020 Mar 30. pii: S0140-6736(20)30755.
    >> Share

  1272. FLAHAULT A
    COVID-19 cacophony: is there any orchestra conductor?
    Lancet. 2020;395:1037.
    >> Share

  1273. USHER AD
    WHO launches crowdfund for COVID-19 response.
    Lancet. 2020;395:1024.
    >> Share

  1274. DANIELS JP
    Venezuelan migrants "struggling to survive" amid COVID-19.
    Lancet. 2020;395:1023.
    >> Share

  1275. HORTON R
    Offline: COVID-19 and the NHS-"a national scandal".
    Lancet. 2020;395:1022.
    >> Share

  1276. THE LANCET
    COVID-19: learning from experience.
    Lancet. 2020;395:1011.
    >> Share

  1277. HOPE MD, Raptis CA, Shah A, Hammer MM, et al
    A role for CT in COVID-19? What data really tell us so far.
    Lancet. 2020 Mar 27. pii: S0140-6736(20)30728.
    >> Share

  1278. MUHAREB R, Giacaman R
    Tracking COVID-19 responsibly.
    Lancet. 2020 Mar 27. pii: S0140-6736(20)30693.
    >> Share

  1279. DALGLISH SL
    COVID-19 gives the lie to global health expertise.
    Lancet. 2020 Mar 26. pii: S0140-6736(20)30739.
    >> Share

  1280. CHOW R
    A citizen's thoughts about COVID-19.
    Lancet. 2020 Mar 26. pii: S0140-6736(20)30692.
    >> Share

  1281. WEBSTER P
    Canada and COVID-19: learning from SARS.
    Lancet. 2020;395:936-937.
    >> Share

  1282. HORTON R
    Offline: COVID-19-a reckoning.
    Lancet. 2020;395:935.
    >> Share

  1283. THE LANCET
    COVID-19: protecting health-care workers.
    Lancet. 2020;395:922.
    >> Share

  1284. MCCLOSKEY B, Zumla A, Ippolito G, Blumberg L, et al
    Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma.
    Lancet. 2020 Mar 20. pii: S0140-6736(20)30681.
    >> Share

  1285. FISHER D, Wilder-Smith A
    The global community needs to swiftly ramp up the response to contain COVID-19.
    Lancet. 2020 Mar 19. pii: S0140-6736(20)30679.
    >> Share

  1286. FLAHAULT A
    COVID-19 cacophony: is there any orchestra conductor?
    Lancet. 2020 Mar 18. pii: S0140-6736(20)30675.
    >> Share

  1287. KANDEL N, Chungong S, Omaar A, Xing J, et al
    Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries.
    Lancet. 2020 Mar 18. pii: S0140-6736(20)30553.
    >> Share

  1288. JACOBSEN KH
    Will COVID-19 generate global preparedness?
    Lancet. 2020 Mar 18. pii: S0140-6736(20)30559.
    >> Share

  1289. TAKIAN A, Raoofi A, Kazempour-Ardebili S
    COVID-19 battle during the toughest sanctions against Iran.
    Lancet. 2020 Mar 18. pii: S0140-6736(20)30668.
    >> Share

  1290. WEISS P, Murdoch DR
    Clinical course and mortality risk of severe COVID-19.
    Lancet. 2020 Mar 17. pii: S0140-6736(20)30633.
    >> Share

  1291. ALWAN NA, Bhopal R, Burgess RA, Colburn T, et al
    Evidence informing the UK's COVID-19 public health response must be transparent.
    Lancet. 2020 Mar 17. pii: S0140-6736(20)30667.
    >> Share

  1292. BEDFORD J, Enria D, Giesecke J, Heymann DL, et al
    COVID-19: towards controlling of a pandemic.
    Lancet. 2020 Mar 17. pii: S0140-6736(20)30673.
    >> Share

  1293. WANG J, Xu C, Wong YK, He Y, et al
    Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic.
    Lancet. 2020 Mar 16. pii: S0140-6736(20)30561.
    >> Share

  1294. PUNG R, Chiew CJ, Young BE, Chin S, et al
    Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures.
    Lancet. 2020 Mar 16. pii: S0140-6736(20)30528.
    >> Share

  1295. MEHTA P, McAuley DF, Brown M, Sanchez E, et al
    COVID-19: consider cytokine storm syndromes and immunosuppression.
    Lancet. 2020 Mar 16. pii: S0140-6736(20)30628.
    >> Share

  1296. REMUZZI A, Remuzzi G
    COVID-19 and Italy: what next?
    Lancet. 2020 Mar 13. pii: S0140-6736(20)30627.
    >> Share

  1297. GHINAI I, McPherson TD, Hunter JC, Kirking HL, et al
    First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.
    Lancet. 2020 Mar 13. pii: S0140-6736(20)30607.
    >> Share

  1298. GREEN MS
    Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term?
    Lancet. 2020 Mar 13. pii: S0140-6736(20)30630.
    >> Share

  1299. ZHOU F, Yu T, Du R, Fan G, et al
    Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30566.
    >> Share

  1300. GARRETT L
    COVID-19: the medium is the message.
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30600.
    >> Share

  1301. WANG T, Du Z, Zhu F, Cao Z, et al
    Comorbidities and multi-organ injuries in the treatment of COVID-19.
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30558.
    >> Share

  1302. ANDERSON RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD, et al
    How will country-based mitigation measures influence the course of the COVID-19 epidemic?
    Lancet. 2020 Mar 9. pii: S0140-6736(20)30567.
    >> Share

  1303. CHEN H, Guo J, Wang C, Luo F, et al
    Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
    Lancet. 2020;395:809-815.
    >> Share

  1304. QIAO J
    What are the risks of COVID-19 infection in pregnant women?
    Lancet. 2020;395:760-762.
    >> Share

  1305. THE LANCET
    COVID-19: too little, too late?
    Lancet. 2020;395:755.
    >> Share

  1306. LEGIDO-QUIGLEY H, Asgari N, Teo YY, Leung GM, et al
    Are high-performing health systems resilient against the COVID-19 epidemic?
    Lancet. 2020 Mar 6. pii: S0140-6736(20)30551.
    >> Share

  1307. WENHAM C, Smith J, Morgan R
    COVID-19: the gendered impacts of the outbreak.
    Lancet. 2020 Mar 6. pii: S0140-6736(20)30526.
    >> Share

  1308. WU Y, Ho W, Huang Y, Jin DY, et al
    SARS-CoV-2 is an appropriate name for the new coronavirus.
    Lancet. 2020 Mar 6. pii: S0140-6736(20)30557.
    >> Share

  1309. FLAHAULT A
    Has China faced only a herald wave of SARS-CoV-2?
    Lancet. 2020 Mar 4. pii: S0140-6736(20)30521.
    >> Share

  1310. WANG G, Zhang Y, Zhao J, Zhang J, et al
    Mitigate the effects of home confinement on children during the COVID-19 outbreak.
    Lancet. 2020 Mar 4. pii: S0140-6736(20)30547.
    >> Share

  1311. LEUNG CC, Lam TH, Cheng KK
    Mass masking in the COVID-19 epidemic: people need guidance.
    Lancet. 2020 Mar 3. pii: S0140-6736(20)30520.
    >> Share

  1312. PECKHAM R
    COVID-19 and the anti-lessons of history.
    Lancet. 2020 Mar 2. pii: S0140-6736(20)30468.
    >> Share

    February 2020
  1313. CHUNG RY, Li MM
    Anti-Chinese sentiment during the 2019-nCoV outbreak.
    Lancet. 2020;395:686-687.
    >> Share

  1314. SHANG L, Zhao J, Hu Y, Du R, et al
    On the use of corticosteroids for 2019-nCoV pneumonia.
    Lancet. 2020;395:683-684.
    >> Share

  1315. CHATTERJEE P
    Indian pharma threatened by COVID-19 shutdowns in China.
    Lancet. 2020;395:675.
    >> Share

  1316. SPINA S, Marrazzo F, Migliari M, Stucchi R, et al
    The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy.
    Lancet. 2020 Feb 28. pii: S0140-6736(20)30493.
    >> Share

  1317. NKENGASONG JN, Mankoula W
    Looming threat of COVID-19 infection in Africa: act collectively, and fast.
    Lancet. 2020 Feb 27. pii: S0140-6736(20)30464.
    >> Share

  1318. MOSS P, Barlow G, Easom N, Lillie P, et al
    Lessons for managing high-consequence infections from first COVID-19 cases in the UK.
    Lancet. 2020 Feb 27. pii: S0140-6736(20)30463.
    >> Share

  1319. EBRAHIM SH, Memish ZA
    COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia.
    Lancet. 2020 Feb 27. pii: S0140-6736(20)30466.
    >> Share

  1320. LIU Y, Eggo RM, Kucharski AJ
    Secondary attack rate and superspreading events for SARS-CoV-2.
    Lancet. 2020 Feb 27. pii: S0140-6736(20)30462.
    >> Share

  1321. CHEN S, Yang J, Yang W, Wang C, et al
    COVID-19 control in China during mass population movements at New Year.
    Lancet. 2020 Feb 24. pii: S0140-6736(20)30421.
    >> Share

  1322. THE LANCET
    COVID-19: fighting panic with information.
    Lancet. 2020;395:537.
    >> Share

  1323. GILBERT M, Pullano G, Pinotti F, Valdano E, et al
    Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study.
    Lancet. 2020 Feb 20. pii: S0140-6736(20)30411.
    >> Share

  1324. CALISHER C, Carroll D, Colwell R, Corley RB, et al
    Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19.
    Lancet. 2020 Feb 19. pii: S0140-6736(20)30418.
    >> Share

  1325. XIANG YT, Li W, Zhang Q, Jin Y, et al
    Timely research papers about COVID-19 in China.
    Lancet. 2020 Feb 17. pii: S0140-6736(20)30375.
    >> Share

  1326. GU X, Cao B, Wang J
    Full spectrum of COVID-19 severity still being depicted - Authors' reply.
    Lancet. 2020 Feb 14. pii: S0140-6736(20)30371.
    >> Share

  1327. XU Z, Li S, Tian S, Li H, et al
    Full spectrum of COVID-19 severity still being depicted.
    Lancet. 2020 Feb 14. pii: S0140-6736(20)30308.
    >> Share

  1328. HEYMANN DL, Shindo N
    COVID-19: what is next for public health?
    Lancet. 2020 Feb 13. pii: S0140-6736(20)30374.
    >> Share

  1329. HABIBI R, Burci GL, de Campos TC, Chirwa D, et al
    Do not violate the International Health Regulations during the COVID-19 outbreak.
    Lancet. 2020 Feb 13. pii: S0140-6736(20)30373.
    >> Share

  1330. SHIMIZU K
    2019-nCoV, fake news, and racism.
    Lancet. 2020 Feb 11. pii: S0140-6736(20)30357.
    >> Share

  1331. CABRINI L, Landoni G, Zangrillo A
    Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure.
    Lancet. 2020 Feb 11. pii: S0140-6736(20)30359.
    >> Share

  1332. ZHANG H
    Early lessons from the frontline of the 2019-nCoV outbreak.
    Lancet. 2020 Feb 11. pii: S0140-6736(20)30356.
    >> Share

  1333. HORTON R
    Offline: 2019-nCoV-"A desperate plea".
    Lancet. 2020;395:400.
    >> Share

  1334. WANG FS, Zhang C
    What to do next to control the 2019-nCoV epidemic?
    Lancet. 2020;395:391-393.
    >> Share

  1335. RUSSELL CD, Millar JE, Baillie JK
    Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
    Lancet. 2020 Feb 7. pii: S0140-6736(20)30317.
    >> Share

  1336. BAO Y, Sun Y, Meng S, Shi J, et al
    2019-nCoV epidemic: address mental health care to empower society.
    Lancet. 2020 Feb 7. pii: S0140-6736(20)30309.
    >> Share

  1337. FAVRE G, Pomar L, Musso D, Baud D, et al
    2019-nCoV epidemic: what about pregnancies?
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30311.
    >> Share

  1338. LU CW, Liu XF, Jia ZF
    2019-nCoV transmission through the ocular surface must not be ignored.
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30313.
    >> Share

  1339. ZUMLA A, Hui DS, Azhar EI, Memish ZA, et al
    Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
    Lancet. 2020 Feb 5. pii: S0140-6736(20)30305.
    >> Share

  1340. RICHARDSON P, Griffin I, Tucker C, Smith D, et al
    Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
    Lancet. 2020 Feb 4. pii: S0140-6736(20)30304.
    >> Share

  1341. HORTON R
    Offline: 2019-nCoV outbreak-early lessons.
    Lancet. 2020;395:322.
    >> Share

  1342. THE LANCET
    Emerging understandings of 2019-nCoV.
    Lancet. 2020;395:311.
    >> Share

    January 2020
  1343. WU JT, Leung K, Leung GM
    Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.
    Lancet. 2020 Jan 31. pii: S0140-6736(20)30260.
    >> Share

  1344. LU R, Zhao X, Li J, Niu P, et al
    Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30251.
    >> Share

  1345. CHEN N, Zhou M, Dong X, Qu J, et al
    Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30211.
    >> Share

  1346. HUANG C, Wang Y, Li X, Ren L, et al
    Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
    Lancet. 2020 Jan 24. pii: S0140-6736(20)30183.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016